Handbook of Biologically Active Peptides

Handbook of Biologically Active Peptides

von: Abba Kastin, Abba J. Kastin (Eds.)

Elsevier Trade Monographs, 2006

ISBN: 9780080463797 , 1640 Seiten

Format: PDF, ePUB, OL

Kopierschutz: DRM

Windows PC,Mac OSX geeignet für alle DRM-fähigen eReader Apple iPad, Android Tablet PC's Apple iPod touch, iPhone und Android Smartphones Online-Lesen für: Windows PC,Mac OSX,Linux

Preis: 240,00 EUR

Mehr zum Inhalt

Handbook of Biologically Active Peptides


 

Front cover

1

Title page

5

Copyright page

6

Table of contents

7

Contributors

21

Preface

41

Foreword

45

I: Plant Peptides Section

47

1: 4-kDa Peptide

47

ABSTRACT

47

DISCOVERY

47

STRUCTURE OF THE PRECURSOR mRNA/GENE

47

DISTRIBUTION OF THE mRNA

47

PROCESSING

48

RECEPTORS

48

ACTIVE AND/OR SOLUTION CONFORMATION

48

BIOLOGICAL ACTIONS

48

References

50

2: AtPep1 Peptides

51

ABSTRACT

51

DISCOVERY

51

STRUCTURE OF AtPep1 AND THE GENE ENCODING THE PRECURSOR PROTEIN ProAtPep1

51

DISTRIBUTION OF ProAtPep1 mRNA

52

PROCESSING OF ProAtPep1

53

AtPep1 RECEPTOR

53

SOLUTION CONFORMATION

53

BIOLOGICAL ACTIONS OF AtPep1

53

Acknowledgments

54

References

54

3: CLAVATA3: A Putative Peptide Ligand Controlling Arabidopsis Stem Cell Specification

55

ABSTRACT

55

DISCOVERY

55

STRUCTURE OF THE PRECURSOR mRNA/GENE

56

RECEPTORS

58

BIOLOGICAL ACTIONS

59

References

60

4: DVL Peptides Are Involved in Plant Development

63

ABSTRACT

63

DISCOVERY

63

STRUCTURE OF THE PRECURSOR mRNA/GENE

64

DISTRIBUTION OF THE DVL1 mRNA

64

PROCESSING

65

RECEPTORS

66

BIOLOGICAL ACTION

66

References

67

5: The POLARIS Peptide

69

ABSTRACT

69

DISCOVERY

69

STRUCTURE OF THE PRECURSOR mRNA/GENE

71

DISTRIBUTION OF THE mRNA

71

PROCESSING

72

BIOLOGICAL ACTIONS

72

References

73

6: Phytosulfokine

75

ABSTRACT

75

INTRODUCTION

75

DISCOVERY AND BIOLOGICAL ACTIONS

75

STRUCTURE OF THE PRECURSOR mRNA/GENE

76

TYROSINE SULFATION

77

RECEPTORS

77

CONCLUSION

77

Acknowledgments

78

References

78

7: RALF Peptides

79

ABSTRACT

79

DISCOVERY

79

STRUCTURE OF THE RALF PEPTIDE AND ITS PRECURSOR cDNA AND GENE

79

DISTRIBUTION OF THE mRNA

80

PROCESSING

80

RECEPTOR

80

SOLUTION CONFORMATION OF RALF

81

BIOLOGICAL ACTION OF RALF

81

Acknowledgment

81

References

82

8: ROTUNDIFOLIA4: A Plant-Specific Small Peptide

83

ABSTRACT

83

DISCOVERY

83

STRUCTURE OF THE PRECURSOR mRNA/GENE

83

DISTRIBUTION OF THE mRNA

84

PROCESSING

84

RECEPTORS

85

BIOLOGICAL ACTIONS

85

References

86

9: The S-Locus Cysteine-Rich Peptide SCR/SP11

87

ABSTRACT

87

DISCOVERY OF SCR

87

STRUCTURE OF THE PRECURSOR mRNA/GENE

89

DISTRIBUTION OF THE mRNA

89

PROCESSING OF THE SCR PROTEIN

90

THE SCR RECEPTOR

90

STRUCTURE

90

BIOLOGICAL ACTIONS

92

References

92

10: Systemins

95

ABSTRACT

95

DISCOVERY OF SYSTEMINS

95

STRUCTURES OF SYSTEMINS AND OF THEIR PRECURSOR cDNAs

96

DISTRIBUTION OF SYSTEMIN SUBFAMILY mRNAs

97

PROCESSING OF THE SYSTEMIN FAMILY PRECURSOR PROTEINS

97

THE LeSys RECEPTOR

98

SOLUTION CONFORMATIONS OF SYSTEMIN SUBFAMILY MEMBERS

98

BIOLOGICAL ACTIONS OF SYSTEMIN FAMILY MEMBERS

98

Acknowledgments

99

References

99

II: Bacterial/Antibiotic Peptides Section

101

11: Cationic Antimicrobial Peptides—The Defensins

101

ABSTRACT

101

DISCOVERY

101

STRUCTURE OF THE PRECURSOR mRNA/GENE

101

DISTRIBUTION AND EXPRESSION OF THE mRNA

102

PROCESSING

104

RECEPTORS

104

ACTIVE CONFORMATION

105

BIOLOGICAL ACTIONS

105

Acknowledgments

111

References

111

12: Cathelicidins: Cationic Host Defense and Antimicrobial Peptides

113

ABSTRACT

113

DISCOVERY

113

STRUCTURE OF THE PRECURSOR mRNA/STRUCTURAL GENE

113

DISTRIBUTION OF CATHELICIDINS

114

PROCESSING

114

RECEPTORS

115

ACTIVE AND/OR SOLUTION CONFORMATION

116

BIOLOGICAL FUNCTIONS

117

Acknowledgments

118

References

118

13: Microcins

121

ABSTRACT

121

DISCOVERY

121

STRUCTURE OF THE PRECURSOR mRNA/STRUCTURAL GENE

121

DISTRIBUTION OF THE mRNA

122

PROCESSING

122

RECEPTORS

124

ACTIVE AND/OR SOLUTION CONFORMATION

124

BIOLOGICAL ACTIONS

125

Acknowledgments

125

References

125

14: Peptaibols

129

ABSTRACT

129

INTRODUCTION

129

CHARACTERISTIC FEATURES OF THE PEPTAIBOLS

129

BIOLOGICAL ORIGINS AND BIOSYNTHESIS OF PEPTAIBOLS

131

PEPTAIBOL STRUCTURES

131

FUNCTIONS AND ACTIVITIES OF PEPTAIBOLS

132

Acknowledgments

133

References

133

15: Nonribosomally Synthesized Microbial Macrocyclic Peptides

135

ABSTRACT

135

STRUCTURAL DIVERSITY OF NRPS SYNTHESIZED PEPTIDES

135

MODULAR STRUCTURE OF NRPSs

136

MACROCYCLIZATION

138

STRUCTURE OF THE SURFACTIN THIOESTERASE DOMAIN

138

BIOCHEMICAL CHARACTERIZATION OF EXCISED THIOESTERASE DOMAINS

139

CHEMOENZYMATIC APPROACHES TOWARD NOVEL CYCLOPEPTIDES

140

THE COMBINATORIAL POTENTIAL OF TE DOMAINS TO SYNTHESIZE CYCLIC PEPTIDE LIBRARIES

141

Acknowledgments

141

References

141

16: Lantibiotics

143

ABSTRACT

143

DISCOVERY

143

STRUCTURE OF THE PRECURSOR mRNA/GENE

143

DISTRIBUTION OF THE mRNA

143

PROCESSING

144

RECEPTORS

144

ACTIVE AND/OR SOLUTION CONFORMATION

144

BIOLOGICAL ACTIONS

146

Acknowledgments

149

References

149

17: The Nonlantibiotic Heat-Stable Bacteriocins in Gram-Positive Bacteria

153

ABSTRACT

153

DISCOVERY

153

SYNTHESIS

153

BIOLOGICAL ACTIONS AND RECEPTORS

156

STRUCTURE

157

FUTURE TRENDS

158

Acknowledgments

158

References

158

18: Colicins: Bacterial/Antibiotic Peptides

161

ABSTRACT

161

DISCOVERY AND CLASSIFICATION

161

STRUCTURE OF THE PRECURSOR mRNA/GENE

161

THE DOMAIN CONCEPT

162

SEQUENCE COMPARISONS

163

X-RAY STRUCTURES OF COLICINS

166

MECHANISM OF IMPORT ACROSS OUTER MEMBRANE

168

AREAS OF RESEARCH ENCOMPASSED BY COLICIN STUDIES

168

Acknowledgment

168

References

168

III: Fungal/Antifungal Peptides Section

171

19: Fungal Peptides with Antifungal Activity

171

ABSTRACT

171

DISCOVERY

171

STRUCTURE

173

BIOLOGICAL ACTION

174

References

174

20: Toxins from Basidiomycete Fungi (Mushroom): Amatoxins, Phallotoxins, and Virotoxins

177

ABSTRACT

177

INTRODUCTION

177

DISCOVERY OF MUSHROOM TOXINS

177

STRUCTURES OF MUSHROOM TOXINS

179

TOXIC ACTIONS OF MUSHROOM TOXINS

179

Acknowledgments

181

References

181

21: Fungal Peptides with Ribonuclease Activity

183

ABSTRACT

183

DISCOVERY

183

STRUCTURE

183

BIOLOGICAL ACTION

185

References

189

22: Fungal Ribosome Inactivating Proteins

191

ABSTRACT

191

DISCOVERY

191

STRUCTURE

192

BIOLOGICAL ACTIONS

192

Acknowledgments

194

References

194

23: Peptides and Depsipeptides from Plant Pathogenic Fungi

197

ABSTRACT

197

PHYTOTOXINS

197

DEPSIPEPTIDES AND PEPTIDES

198

CONCLUSION

201

References

202

IV: Invertebrate Peptides Section

203

24: Insect Diuretic and Antidiuretic Hormones

203

ABSTRACT

203

DISCOVERY

203

STRUCTURE OF THE PRECURSOR mRNA/GENE

204

DISTRIBUTION OF mRNA AND PEPTIDES

205

PEPTIDE PROCESSING

205

RECEPTORS

205

STRUCTURE-ACTIVITY AND ACTIVE CONFORMATION

206

BIOLOGICAL ACTIONS

206

CONCLUSION

207

References

207

25: Developmental Peptides: ETH, Corazonin, and PTTH

209

ABSTRACT

209

DISCOVERY

209

STRUCTURE OF THE PRECURSOR mRNA/GENE AND PEPTIDE PROCESSING

210

PTTH

211

DISTRIBUTION OF THE mRNA AND PEPTIDES

212

PTTH

212

RECEPTORS

212

ACTIVE AND/OR SOLUTION CONFORMATION

213

BIOLOGICAL ACTIONS

213

PTTH

214

References

214

26: Tachykinins and Tachykinin-Related Peptides in Invertebrates

217

ABSTRACT

217

DISCOVERY

217

STRUCTURE OF THE PRECURSOR mRNA/GENE

218

DISTRIBUTION OF mRNA AND PEPTIDES

219

PEPTIDE PROCESSING

220

RECEPTORS OF TKRPs

220

STRUCTURE-ACTIVITY AND ACTIVE CONFORMATION

221

BIOLOGICAL ACTIONS

221

CONCLUSION

221

References

222

27: Proctolin in Insects

223

ABSTRACT

223

DISCOVERY

223

STRUCTURE OF THE PRECURSOR mRNA/GENE

223

DISTRIBUTION OF mRNA

223

PROCESSING

224

RECEPTORS

225

STRUCTURE—ACTIVITY AND ACTIVE CONFORMATION

225

BIOLOGICAL ACTIONS

226

References

227

28: Sulfakinins

229

ABSTRACT

229

DISCOVERY

229

STRUCTURE OF THE PRECURSOR mRNA/GENE

229

PROCESSING

230

TISSUE DISTRIBUTION

230

RECEPTORS

231

STRUCTURE/CONFORMATION-ACTIVITY RELATIONSHIPS

231

BIOLOGICAL ACTIONS

232

References

232

29: The Invertebrate AKH/RPCH Family

235

ABSTRACT

235

DISCOVERY

235

PEPTIDE AND PRECURSOR STRUCTURE AND PROCESSING

235

DISTRIBUTION

236

SOLUTION CONFORMATION OF AKH AND RECEPTORS FOR AKH

236

BIOLOGICAL ACTIONS

237

Acknowledgments

238

References

238

30: Insect Myosuppressins/FMRFamides and FL/IRFamides/NPFs

239

ABSTRACT

239

DISCOVERY

239

STRUCTURE OF THE PRECURSOR mRNA/GENE

240

DISTRIBUTION OF mRNA

241

PROCESSING

242

RECEPTORS

242

STRUCTURE–ACTIVITY AND ACTIVE CONFORMATION

243

BIOLOGICAL ACTION

244

References

245

31: Allatostatins in the Insects

247

ABSTRACT

247

DISCOVERY

247

STRUCTURE OF ALLATOSTATIN PRECURSORS

247

DISTRIBUTION OF mRNA AND PEPTIDES

248

PEPTIDE PROCESSING

249

ALLATOSTATIN RECEPTORS

249

STRUCTURE–ACTIVITY AND ACTIVE CONFORMATIONS

250

BIOLOGICAL ACTIONS

251

CONCLUSION

251

References

251

32: The FXPRLamide (Pyrokinin/PBAN) Peptide Family

253

ABSTRACT

253

DISCOVERY

253

STRUCTURE OF THE PRECURSOR mRNA/GENE

253

DISTRIBUTION OF mRNA AND PEPTIDES

254

PEPTIDE PROCESSING

255

RECEPTORS OF IXPRLamides

256

STRUCTURE–ACTIVITY RELATIONSHIPS AND ACTIVE CONFORMATION

256

BIOLOGICAL ACTIONS

257

References

257

33: Insect Pigment Dispersing Factor and Bursicon

259

ABSTRACT

259

INSECT PIGMENT DISPERSING FACTOR

259

BURSICON

261

References

265

34: Crustacean Bioactive Peptides

267

ABSTRACT

267

INTRODUCTION

267

PROCTOLIN

267

CRUSTACEAN CARDIOACTIVE PEPTIDE

267

SULFAKININS

270

NEUROPEPTIDE F

270

OPIOID–ENKEPHALIN

270

ORCOKININ AND ORCOMYOTROPIN

271

ALLATOSTATIN

271

TACHYKININ-RELATED PEPTIDES

272

KININS

272

PYROKININ/PBAN

272

SIFAMIDE

272

MISCELLANEOUS

273

References

273

35: Crustacean Chromatophorotrophins and Hyperglycemic Hormone Peptide Families

275

ABSTRACT

275

INTRODUCTION

275

CHROMATOPHOROTROPHIC HORMONES

275

CRUSTACEAN HYPERGLYCEMIC HORMONES

276

References

279

36: Molluscan Bioactive Peptides

281

ABSTRACT

281

FMRFamide, FMRFamide-RELATED PEPTIDES (FaRPs)

281

PEPTIDES AND METABOLISM: ENERGY FLOW AND GROWTH

282

PEPTIDES AND FEEDING BEHAVIOR

283

PEPTIDES AND RENAL FUNCTION

284

TACHYKININS

284

References

285

37: Molluscan Peptides and Reproduction

287

ABSTRACT

287

PEPTIDES AND REPRODUCTION

287

DISCOVERY

289

VP/OT: DISCOVERY

289

PHEROMONES: DISCOVERY

290

References

291

38: Free-Living Nematode Peptides

293

ABSTRACT

293

INTRODUCTION

293

FMRFamide-LIKE PEPTIDES (FLPs)

293

NEUROPEPTIDE-LIKE PEPTIDES (NLPs)

296

INSULINS (INSs)

296

ANTIMICROBIAL PEPTIDES

298

Acknowledgment

299

References

299

39: Parasitic Nematode Peptides

301

ABSTRACT

301

INTRODUCTION

301

FMRFamide-LIKE PEPTIDES (FLPs)

301

TKQELE

305

References

305

V: Amphibian Peptides Section

307

40: Amphibian Tachykinins

307

ABSTRACT

307

DISCOVERY

307

STRUCTURE OF THE PRECURSOR mRNA/GENE

308

AMPHIBIAN TK DISTRIBUTION

309

RECEPTORS

310

ACTIVE AND/OR SOLUTION CONFORMATION

310

BIOLOGICAL ACTIONS

310

PATHOLOGICAL IMPLICATIONS

313

References

313

41: Opioid Peptides from Frog Skin and Bv8-Related Peptides

315

ABSTRACT

315

OPIOID PEPTIDES

315

A BRIEF HISTORY

315

STRUCTURE AND CONFORMATION

316

BIOLOGICAL ACTIONS

317

Bv8/PROKINETICIN FAMILY (SWISS-PROT: Q9PW66)

318

References

320

42: Amphibian Bombesin-like Peptides

323

ABSTRACT

323

INTRODUCTION

323

AMPHIBIAN BOMBESINS

323

AMPHIBIAN PHYLLOLITORINS

325

RANATENSIN-LIKE PEPTIDES

325

GASTRIN-RELEASING PEPTIDE

326

PHYLOGENETIC CONSIDERATIONS AND IMPLICATIONS FOR ADDITIONAL MAMMALIAN BOMBESIN-LIKE PEPTIDES

326

References

327

43: Host Defense Peptides from Australian Amphibians: Caerulein and Other Neuropeptides

329

ABSTRACT

329

INTRODUCTION

329

THE CAERULEIN PEPTIDES

329

PEPTIDES RELATED TO CAERULEIN

331

TRYPTOPHYLLIN PEPTIDES

332

DISULFIDE NEUROPEPTIDES FROM THE GENUS CRINIA

333

Acknowledgments

333

References

333

44: Bradykinin-Related Peptides from Frog Skin

337

ABSTRACT

337

DISCOVERY AND DISTRIBUTION

337

BIOSYNTHESIS OF BRADYKININ AND RELATED PEPTIDES

337

MOLECULAR VARIANTS OF BK

338

BIOLOGICAL ACTIVITIES

339

References

340

45: The Dermaseptins

341

ABSTRACT

341

THE DERMASEPTIN SUPERFAMILY

341

THE PREPRODERMASEPTINS

343

ACTIVITIES OF THE PREPRODERMASEPTINDERIVED PEPTIDES

346

STRUCTURAL FEATURES AND MECHANISMS OF MICROBICIDAL ACTIVITY

347

References

349

46: The Temporins

351

ABSTRACT

351

DISCOVERY

351

BIOSYNTHESIS OF THE TEMPORINS

352

MOLECULAR HETEROGENEITY OF THE TEMPORINS

353

BIOLOGICAL ACTIVITIES OF THE TEMPORINS

353

POTENTIAL CLINICAL AND COMMERCIAL APPLICATIONS

354

References

354

47: Chromogranins/Secretogranins and Derived Peptides: Insights from the Amphibian Model

357

ABSTRACT

357

DISCOVERY

357

STRUCTURE OF THE PRECURSOR mRNA/GENE

357

DISTRIBUTION OF THE mRNA

360

BIOLOGICAL ACTIONS

362

Acknowledgments

364

References

364

48: Sodefrin and Related Pheromones

367

ABSTRACT

367

DISCOVERY

367

STRUCTURE OF THE PRECURSOR mRNA/GENE

368

DISTRIBUTION OF THE mRNA

369

PROCESSING OF THE PRECURSORS

369

RECEPTORS

369

STRUCTURE–ACTIVITY RELATIONSHIPS

371

BIOLOGICAL ACTIONS

371

PHYSIOLOGICAL IMPLICATION

372

References

372

49: Amphibian Neurohypophysial Peptides

373

ABSTRACT

373

DISCOVERY

373

STRUCTURE OF THE PRECURSOR mRNA/GENE

373

DISTRIBUTION OF AVT AND MT

374

RECEPTOR STRUCTURE AND DISTRIBUTION

374

MAJOR BIOLOGICAL ACTIONS OF AVT AND MT

374

STRUCTURE AND FUNCTION OF HYDRINS

375

References

376

50: Bombinins

379

ABSTRACT

379

DISCOVERY

379

SOLUTION CONFORMATION

381

STRUCTURE OF THE PRECURSOR mRNA/GENE

381

BIOLOGICAL ACTIVITY

381

MODE OF ACTION STUDIES

382

Acknowledgments

383

References

383

VI: Venom Peptides Section

385

51: Scorpion Venom Peptides

385

INTRODUCTION

385

DISCOVERY AND DOCUMENTED BIODIVERSITY

385

THREE-DIMENSIONAL FOLDING

386

SCORPION TOXIN PRECURSORS

387

RECEPTOR SITES

387

MOLECULAR BASIS OF THEIR ACTIVITY

387

CONCLUSION

389

Acknowledgments

389

References

389

52: Snake Venom Peptides

401

ABSTRACT

401

INTRODUCTION

401

THREE-FINGER TOXINS

401

PROTEASE INHIBITOR HOMOLOGS

404

CROTAMINE-LIKE MYOTOXINS

405

SARAFOTOXINS

405

CRISP FAMILY TOXINS

405

NATRIURETIC PEPTIDES

405

DISINTEGRINS

406

C-TYPE LECTINS AND LECTIN-LIKE PROTEINS

406

WAGLERINS

406

BRADYKININ-POTENTIATING PEPTIDES

406

AVIT PEPTIDES

407

MISCELLANEOUS PEPTIDES

407

References

408

53: Sea Anemone Venom Peptides

409

ABSTRACT

409

INTRODUCTION

409

ION CHANNEL BLOCKERS AND MODULATORS

409

CYTOLYSINS

411

OTHER BIOACTIVE PEPTIDES

412

Acknowledgments

412

References

412

54: Spider Venom Peptides

415

ABSTRACT

415

INTRODUCTION

415

METHODOLOGICAL APPROACHES IN THE ISOLATION OF NOVEL SPIDER VENOM PEPTIDES

415

STRUCTURE OF THE PRECURSOR SPIDER VENOM PEPTIDE AND POSTTRANSLATIONAL PROCESSING

416

STRUCTURAL ORGANIZATION OF SPIDER VENOM PEPTIDES: VARIATIONS ON AN ANCESTRAL FOLD

416

SPIDER PEPTIDE TOXINS MODULATING Nav CHANNEL FUNCTION: BLOCKERS AND GATING MODIFIERS

416

SPIDER PEPTIDE TOXINS MODULATING VOLTAGE-GATED POTASSIUM CHANNELS

420

SPIDER PEPTIDE TOXINS MODULATING ON Cav CHANNELS

421

SPIDER PEPTIDE TOXINS ACTING ON ACID-SENSING ION CHANNELS

422

SPIDER PEPTIDE TOXINS WITH NONSELECTIVE ACTIONS ON VOLTAGE-GATED ION CHANNELS: PROMISCUOUS TOXINS

422

SPIDER PEPTIDE TOXINS ACTING ON MECHANOSENSITIVE ION CHANNELS

422

SPIDER TOXINS ACTING ON GLUTAMATE RECEPTORS OR TRANSPORTERS

422

SPIDER TOXINS ACTING ON NEUROTRANSMITTER RELEASE (PRESYNAPTIC TOXINS)

423

SPHINGOMYELINASES D TOXINS FROM SPIDER VENOMS

423

ANTIMICROBIAL AND CYTOLYTIC PEPTIDE TOXINS FROM SPIDER VENOM

424

CONCLUSION

425

References

425

55: Conus Snail Venom Peptides

427

ABSTRACT

427

INTRODUCTION: THE BIODIVERSITY OF VENOMOUS MOLLUSCS

427

DISCOVERY OF CONOTOXINS

427

PRECURSOR STRUCTURE, EXPRESSION, AND PROCESSING: CONOTOXIN SUPERFAMILIES

428

DEFINITION OF CONOTOXIN FAMILIES, RECEPTOR TARGETS, STRUCTURES

430

BIOLOGICAL MECHANISMS, THERAPEUTIC APPLICATIONS

432

Acknowledgments

433

References

433

56: Insect Venom Peptides

435

ABSTRACT

435

INTRODUCTION

435

PEPTIDES FROM THE VENOMS OF SOCIAL HYMENOPTERA

436

PEPTIDE TOXINS FROM SOCIAL WASPS

437

PEPTIDES FROM THE VENOMS OF SOLITARY WASPS

438

PEPTIDES FROM ANT VENOMS

439

Aknowledgments

440

References

440

57: Worm Venom Peptides

443

ABSTRACT

443

INTRODUCTION

443

NEMERTINE PEPTIDE NEUROTOXINS

444

NEMERTINE PEPTIDE CYTOLYSINS

445

ANNELID (GLYCERA) NEUROTOXIN

445

PEPTIDE CYTOLYSINS FROM OTHER WORM PHYLA

446

CONCLUSION

446

References

446

58: Targets and Therapeutic Properties of Venom Peptides

449

ABSTRACT

449

ANTICOAGULANTS AND THROMBOLYTIC AGENTS

449

ANTIHYPERTENSIVE AGENTS

456

ANTIARRHYTHMIC AGENTS

456

CONGESTIVE HEART FAILURE

456

ANTIMICROBIAL PEPTIDES

456

IMMUNOMODULATORY PEPTIDES

457

ANTITUMOR PEPTIDES

457

ANALGESIA

458

DIABETES MELLITUS

458

Acknowledgments

458

References

458

59: Structure-Function Strategies to Improve the Pharmacological Value of Animal Toxins

461

ABSTRACT

461

CHEMICAL SYNTHESIS VERSUS GENETIC ENGINEERING

461

PEPTIDE IMPROVEMENT

461

DESIGN OF NOVEL PEPTIDE ANALOGS

462

BENEFITS OF SIZE REDUCTION IN PEPTIDES

462

RELEVANCE OF CHIMERA AND LABELING APPROACHES

462

STRATEGIES IMPLYING A CHANGE IN THE PATTERN OF HALF-CYSTINE PAIRS

463

WHAT ABOUT THE DIPOLE MOMENT OF VENOM PEPTIDES?

464

FUNCTIONAL DERIVATION OF VENOM PEPTIDES

464

IMPROVING PEPTIDE STABILITY

464

CONCLUSION

465

References

465

VII: Cancer/Anticancer Peptides Section

467

60: Analogs of Luteinizing Hormone-Releasing Hormone (LHRH) in Cancer

467

ABSTRACT

467

INTRODUCTION

467

ANTAGONISTS OF LHRH

468

RECEPTORS FOR LHRH ON TUMORS

468

CYTOTOXIC LHRH ANALOGS

469

EFFECTS OF ANALOGS OF LHRH ON TUMORS

469

CYTOTOXIC ANALOGS OF LHRH

469

SIDE EFFECTS OF CYTOTOXIC LHRH ANALOGS

471

CONCLUSION

472

References

472

61: Bombesin-Related Peptides and Neurotensin: Effects on Cancer Growth/Proliferation and Cellular Signaling in Cancer

475

ABSTRACT

475

INTRODUCTION

475

BN-RELATED PEPTIDES (GRP, NMB)

475

NEUROTENSIN (NT)

477

References

478

62: Somatostatin and NPY

481

ABSTRACT

481

INTRODUCTION

481

SOMATOSTATIN

481

NPY

484

References

486

63: Bradykinin and Cancer

489

ABSTRACT

489

INTRODUCTION

489

KININ CHEMISTRY AND BIOLOGY

489

BRADYKININ ANTAGONISTS

490

BRADYKININ AND CANCER

491

References

492

64: Endothelin

493

ABSTRACT

493

ENDOTHELIN-1

493

ET-1 ASSOCIATED SIGNAL TRANSDUCTION PATHWAYS

493

ENDOTHELIN EXPRESSION IN CANCER

493

ENDOTHELIN RECEPTOR EXPRESSION IN CANCER

494

ENDOTHELIN AS A MITOGEN

495

ENDOTHELIN AND APOPTOSIS

495

ENDOTHELIN AND ANGIOGENESIS

495

ENDOTHELIN-1 AND TUMOR PROGRESSION/METASTASES

496

ENDOTHELIN ANTAGONISM IN VIVO

496

CLINICAL TRIALS

496

References

496

65: Adrenomedullin: An Esoteric Juggernaut of Human Cancers

499

ABSTRACT

499

INTRODUCTION

499

AM EXPRESSION

499

GROWTH REGULATION

500

ANTIAPOPTOSIS

500

MIGRATION/INVASION

501

ANGIOGENESIS

501

IMMUNE REGULATION

501

THERAPEUTIC STRATEGIES AND CONCLUSION

502

References

502

66: Angiotensin Peptides and Cancer

505

ABSTRACT

505

INTRODUCTION

505

ACE AND AT1 RECEPTOR POLYMORPHISMS AND CANCER

506

EFFECTS OF ACE INHIBITORS AND ARBs ON CANCER CELL GROWTH AND TUMORIGENESIS

506

MECHANISMS OF ACTION OF ANG II

507

INHIBITION OF HUMAN CANCER CELL GROWTH BY ANG-(1-7)

508

CONCLUSION

509

References

509

67: Gastrin and Cancer

513

ABSTRACT

513

INTRODUCTION

513

EXPRESSION OF GASTRINS IN NORMAL TISSUE

513

THE GASTRIN RECEPTOR(S)

514

EXPRESSION OF GASTRIN IN TUMORS

514

GASTRIN AS A TUMOR GROWTH FACTOR

515

CONCLUSION

515

References

516

68: VIP and PACAP as Autocrine Growth Factors in Breast and Lung Cancer

519

ABSTRACT

519

INTRODUCTION

519

VIP/PACAP PEPTIDES

519

VIP RECEPTORS

520

SECOND MESSENGERS

520

PROLIFERATION

521

TUMOR IMAGING

521

CONCLUSION

521

References

522

69: Oxytocin and Cancer

525

ABSTRACT

525

MOVING FROM PHYSIOLOGY TO NEOPLASTIC PATHOLOGY

525

OT AS A MODULATOR OF CELL GROWTH IN OTR-EXPRESSING TUMORS

526

THE OT/OTR SYSTEM AND CANCER

527

References

527

70: Antagonists of Growth Hormone–Releasing Hormone (GHRH) in Cancer

529

ABSTRACT

529

INTRODUCTION

529

THERAPEUTIC INDICATIONS OF GHRH ANTAGONISTS

530

ANTAGONISTIC ANALOGS OF GHRH

530

GHRH AND GHRH RECEPTORS IN HUMAN CANCERS

531

MECHANISMS OF TUMOR INHIBITION BY GHRH ANTAGONISTS

532

INHIBITORY EFFECTS OF GHRH ANTAGONISTS ON HUMAN EXPERIMENTAL CANCERS IN VIVO

532

CONCLUSION

533

References

534

VIII: Vaccine Peptides Section

537

71: Cancer Immunotherapy with Rationally Designed Synthetic Peptides

537

ABSTRACT

537

CANCER IMMUNOTHERAPY

537

CURRENT VACCINATION STRATEGIES

538

ACTIVE IMMUNOTHERAPEUTIC STRATEGIES USING PEPTIDES

539

IDENTIFICATION OF T AND B CELL EPITOPES

540

RATIONAL DESIGN OF PEPTIDE VACCINES

541

ANTITUMOR IMMUNITY WITH PEPTIDE VACCINES

542

CONCLUSION

542

References

543

72: Peptide Vaccines for Cancer Treatment

545

ABSTRACT

545

USING THE IMMUNE SYSTEM TO TREAT CANCER

545

IDENTIFICATION OF TUMOR ANTIGENS AND PEPTIDES USING ENDOGENOUS IMMUNITY PRESENT IN CANCER PATIENTS

546

COMMON TUMOR ANTIGENS AND ANTIGENIC PEPTIDES RECOGNIZED BY T CELLS

546

FEATURES OF TUMOR-SPECIFIC T CELLS

548

CLINICAL TRIALS OF PEPTIDE BASED CANCER VACCINES

548

STRATEGIES FOR ENHANCING THE EFFICACY OF PEPTIDE-BASED VACCINES

549

CONCLUSION

550

Acknowledgments

550

References

550

73: Antiadhesin Synthetic Peptide Consensus Sequence Vaccine and Antibody Therapeutic for Pseudomonas Aeruginosa

553

ABSTRACT

553

DISEASE TARGET

553

BACKGROUND AND AVAILABLE THERAPIES

553

WHY PEPTIDES

554

CONTRIBUTIONS

556

FUTURE OUTLOOK

559

CONCLUSION

559

References

560

74: Peptide Vaccines for Malaria

561

ABSTRACT

561

INTRODUCTION

561

MALARIAL VACCINES

562

MAIN MALARIAL ANTIGENS INVOLVED IN TARGET CELL BINDING

563

VACCINE DESIGN BASED ON A STRUCTURAL-FUNCTION RELATIONSHIP

564

DESIGN BASED ON THE MHC-PEPTIDE-TCR COMPLEX CONFORMATION

566

DESIGN BASED ON STRUCTURALLY MODIFIED ANTIGEN BINDING TO HLADRb1* MOLECULES

567

DESIGN BASED ON MALARIAL ANTIGENS’ STRUCTURAL MODIFICATION BY INTRODUCING PEPTIDE BOND ISOSTERS

568

CONCLUSION

570

Acknowledgments

570

References

570

75: Peptide Vaccine for Otitis Media

573

ABSTRACT

573

DISEASE TARGET

573

BACKGROUND OF AVAILABLE THERAPIES

573

WHY PEPTIDES?

574

OUR CONTRIBUTIONS TO THE AREA

577

FUTURE OUTLOOK

578

References

578

76: Peptide Vaccine for Alzheimer’s Disease

581

ABSTRACT

581

INTRODUCTION

581

IN VITRO MODULATION OF b-AMYLOID FORMATION

581

EFRH PHAGE ELICITS ANTIBODIES AGAINST b-AMYLOID PEPTIDE

582

PEPTIDES AS VACCINES FOR PREVENTION AND/OR REDUCTION OF AMYLOID PLAQUES IN AD TRANSGENIC MICE

583

ACTIVE IMMUNIZATION OF hAPP TRANSGENIC MICE WITH EFRH-PHAGE AS PEPTIDE VACCINE

584

FUTURE OUTLOOK

585

Acknowledgments

585

References

585

77: Peptide Dendrimers as Immunogens

587

ABSTRACT

587

INTRODUCTION

587

BACKGROUND AND DISCOVERY

587

DESIGN OF PEPTIDE DENDRIMERS AS IMMUNOGENS

588

IMMUNOLOGICAL PROPERTY OF MAPs

589

CELL-MEDIATED RESPONSES INDUCED BY LIPIDATED MAPs

589

REASONS FOR INCREASED IMMUNOGENICITY

590

SYNTHESIS

590

CONTRIBUTION AND FUTURE OUTLOOK

591

References

592

IX: Immunological and Inflammatory Peptides Section

593

78: Chemotactic Peptide Ligands for Formylpeptide Receptors Influencing Inflammation

593

ABSTRACT

593

BACKGROUND

593

FORMYLPEPTIDE RECEPTORS

593

AGONIST PEPTIDES OF FPRs

594

MAMMALIAN PEPTIDES

595

PERSPECTIVES

597

Acknowledgments

597

References

597

79: Complement-Derived Inflammatory Peptides: Anaphylatoxins

599

ABSTRACT

599

HISTORICAL PERSPECTIVE AND SCOPE

599

PRECURSOR mRNA/GENE STRUCTURE, EXPRESSION, AND REGULATION OF ANAPHYLATOXINS

599

GENERATION OF C3a AND C5a ANAPHYLATOXINS

600

STRUCTURE OF ANAPHYLATOXINS

601

RECEPTORS FOR ANAPHYLATOXINS

602

BIOLOGICAL ACTIONS OF ANAPHYLATOXINS

602

PATHOPHYSIOLOGICAL IMPLICATIONS OF ANAPHYLATOXINS

603

Acknowledgment

603

References

603

80: Chemokines: A New Peptide Family of Neuromodulators

605

ABSTRACT

605

DISCOVERY

606

STRUCTURE OF THE PRECURSOR mRNA/GENE

606

DISTRIBUTION OF SDF-1 mRNA AND PROTEIN

606

PROCESSING OF THE PRECURSOR

608

RECEPTORS AND SIGNALING CASCADES

608

RECEPTOR EXPRESSION AND DISTRIBUTION

608

CONFORMATION

609

BIOLOGICAL ACTIONS

609

PATHOPHYSIOLOGICAL IMPLICATIONS

610

References

610

81: Immune Peptides Related to Dipeptidyl Aminopeptidase IV/CD26

613

ABSTRACT

613

INTRODUCTION

613

DP IV/CD26 IN THE IMMUNE SYSTEM

613

DP IV EFFECTOR PEPTIDES

614

PRIMARY DP IV EFFECTOR PEPTIDES

615

SECONDARY IMMUNORELEVANT DP IV PEPTIDE SUBSTRATES

616

PEPTIDE INHIBITORS OF DP IV

617

References

617

82: RGD-Peptides and Some Immunological Problems

619

ABSTRACT

619

DISCOVERY OF THE ANTIADHESIVE RGD-PEPTIDES

619

RGD-PEPTIDES IN PLATELET AGGREGATION

620

BIOLOGICALLY ACTIVE CONFORMATION OF RGD-PEPTIDES

621

RGD PEPTIDES IN IMMUNOLOGICAL PHENOMENA

621

RGD-PEPTIDES AND PATHOGEN INVASIONS

622

RGD-PEPTIDES IN OTHER PATHOLOGICAL PHENOMENA

622

RGD RETROSEQUENCES IN PROTEINS

623

References

623

83: Neuropeptides That Regulate Immune Responses

625

ABSTRACT

625

Acknowledgment

628

References

628

84: Peptides as Targets of T Cell-Mediated Immune Responses

631

ABSTRACT

631

INTRODUCTION

631

MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I AND CLASS II MOLECULES

632

CHARACTERISTICS OF PEPTIDES PRESENTED BY MHC-CLASS I

633

CHARACTERISTICS OF PEPTIDES PRESENTED BY MHC-CLASS II

634

BIOLOGICAL ROLES OF MHC-BOUND PEPTIDES

635

AUTOIMMUNE DISEASES

636

THERAPEUTIC USE OF PEPTIDES

637

CONCLUSION

638

References

638

85: The Use of Positional Scanning Synthetic Peptide Combinatorial Libraries to Identify Immunological Relevant Peptides

641

ABSTRACT

641

DEFINITION OF POSITIONAL SCANNING SYNTHETIC COMBINATORIAL PEPTIDE LIBRARIES (PS-SCL)

641

USE OF PS-SCL TO DETERMINE ANTIBODY LIGANDS

642

USE OF PS-SCL FOR T CELL EPITOPE MAPPING

644

USE OF PS-SCL TO IDENTIFY MHC BINDING MOTIFS

645

CONCLUSION

646

References

646

86: Copolymer 1 and Related Peptides as Immunomodulating Agents

649

ABSTRACT

649

INTRODUCTION

649

SUPPRESSION OF EAE BY GA

650

OTHER PEPTIDES RELATED TO MS

650

CLINICAL TRIALS WITH COPOLYMER 1

651

MECHANISM OF ACTION OF GLATIRAMER ACETATE

651

IN SITU IMMUNOMODULATION AND NEUROGENRATION IN THE CNS

652

POTENTIAL OF GA FOR THE SUPPRESSION OF OTHER AUTOIMMUNE DISORDERS—STUDIES ON INFLAMMATORY BOWEL DISEASES

653

EFFECT OF COPOLYMER 1 ON GRAFT REJECTION

653

CONCLUSION

654

References

654

87: CLIP—A Multifunctional MHC Class II–Associated Self-Peptide

657

ABSTRACT

657

INTRODUCTION

657

THE CLIP RECEPTORS: MHC CLASS II MOLECULES

657

PROTEOLYSIS OF II AND GENERATION OF CLIP

660

FLANKING RESIDUES AND SELF-RELEASE OF CLIP

661

A CHAPERONE FACILITATING CLIP RELEASE: HLA-DM/H2-DM

661

MEMBRANE MICRODOMAINS

662

CLIP AS AN ANTAGONIST OF TH1 POLARIZATION

663

CONCLUSION

664

References

665

X: Brain Peptides Section

667

88: Vasopressin and Oxytocin

667

ABSTRACT

667

DISCOVERY

667

STRUCTURE OF THE PRECURSOR mRNA/GENE

668

DISTRIBUTION OF THE mRNA

669

PROCESSING OF THE PRECURSOR

670

RECEPTORS

671

ACTIVE AND/OR SOLUTION CONFORMATION

672

BIOLOGICAL ACTIONS WITHIN THE BRAIN AND PITUITARY

672

PATHOPHYSIOLOGICAL IMPLICATIONS

672

References

673

89: Thyrotrophin-Releasing Hormone: New Functions for an Ancient Peptide

675

ABSTRACT

675

DISCOVERY OF TRH

675

STRUCTURE OF THE PRECURSOR mRNA/GENE

675

DISTRIBUTION OF PRE-PROTRH mRNA AND PRE-PRO-TRH-DERIVED PEPTIDES

676

PROCESSING OF THE TRH PRECURSOR

676

DISTRIBUTION OF TRH RECEPTORS AND THE TRH DEGRADING ENZYME

676

TRH RECEPTOR SIGNALING CASCADES

677

BIOLOGICAL ACTIONS OF TRH WITHIN THE BRAIN AND PITUITARY

677

PATHOPHYSIOLOGICAL IMPLICATIONS

679

References

679

90: Gonadotrophin Releasing Hormone

681

ABSTRACT

681

DISCOVERY AND BACKGROUND

681

STRUCTURE OF GnRHS AND THEIR PRECURSORS

681

GnRH DISTRIBUTION

683

PROCESSING OF THE GnRH PRECURSOR

684

GnRH RECEPTORS AND SIGNALLING CASCADES

684

PHYSICAL STRUCTURE OF GnRH

688

BIOLOGICAL ACTIONS

688

PATHOPHYSIOLOGY

689

References

690

91: Brain Somatostatin-Related Peptides

691

ABSTRACT

691

DISCOVERY

691

STRUCTURE OF THE PRECURSOR mRNA/GENE

691

DISTRIBUTION OF THE mRNAs AND PEPTIDES

692

PROCESSING OF THE PRECURSORS AND DEGRADATION OF THE PEPTIDE

694

RECEPTORS AND SIGNALING CASCADES

694

INFORMATION ON ACTIVE AND/OR SOLUTION CONFORMATION

696

BIOLOGICAL ACTIONS WITHIN THE BRAIN AND PITUITARY

697

PATHOPHYSIOLOGICAL IMPLICATIONS

697

References

699

92: Corticotrophin-Releasing Hormone (CRH) Peptide Family

701

ABSTRACT

701

DISCOVERY

701

STRUCTURE OF THE PRECURSOR mRNA/GENE

702

DISTRIBUTION AND EXPRESSION OF mRNA

704

PROCESSING OF PREPROHORMONE

704

RECEPTORS AND BINDING PROTEINS

706

BIOLOGICAL ACTIONS IN THE CENTRAL NERVOUS SYSTEM

706

PATHOPHYSIOLOGICAL IMPLICATIONS

707

References

707

93: Growth Hormone-Releasing Hormone

709

ABSTRACT

709

DISCOVERY OF GHRH

709

STRUCTURE OF THE PRECURSOR mRNA/GENE

709

EXPRESSION OF GHRH IN THE BRAIN

710

PROCESSING OF GHRH PRECURSOR

711

GHRH RECEPTOR

711

GHRH SIGNALING

713

CONFORMATION OF GHRH AND SYNTHESIS OF ANALOGS

714

BIOLOGICAL ACTIVITY OF GHRH

714

PATHOPHYSIOLOGICAL IMPLICATIONS

715

References

715

94: PACAP/VIP

719

ABSTRACT

719

DISCOVERY

719

STRUCTURE OF THE PRECURSOR mRNA/GENE

719

DISTRIBUTION OF THE mRNA

720

PROCESSING OF THE PRECURSOR

720

RECEPTORS AND SIGNALING CASCADES

722

SOLUTION STRUCTURE COMPARISON

723

BIOLOGICAL ACTIONS IN THE BRAIN AND THE PITUITARY

723

PATHOPHYSIOLOGY OF PACAP/VIP

725

References

726

95: Neuropeptide Y

729

ABSTRACT

729

DISCOVERY OF NPY AND HOMOLOGS

729

STRUCTURE OF THE PRECURSOR mRNA/GENE

729

PROCESSING OF THE NPY PRECURSOR

731

DISTRIBUTION OF NPY mRNA AND PROTEIN

731

STRUCTURE OF NPY-LIKE PEPTIDES

732

RECEPTORS AND SIGNALING CASCADES

732

BIOLOGICAL ACTIONS

732

PATHOPHYSIOLOGICAL IMPLICATIONS

733

Acknowledgment

733

References

733

96: Melanocortins

735

ABSTRACT

735

DISCOVERY

735

STRUCTURE OF THE PROOPIOMELANOCORTIN mRNA/GENE

735

DISTRIBUTION OF POMC mRNA AND MELANOCORTINS IN THE BRAIN

736

PROCESSING OF PROOPIOMELANOCORTIN

737

CONTROL OF BIOSYNTHESIS AND RELEASE OF BRAIN MELANOCORTINS

738

MELANOCORTIN RECEPTOR FAMILY

738

STRUCTURE–ACTIVITY RELATIONSHIPS FOR MELANOCORTINS

738

BIOLOGICAL ACTIONS WITHIN THE BRAIN

739

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS

741

References

741

97: Cocaine- and Amphetamine-Regulated Transcript (CART)

743

ABSTRACT

743

DISCOVERY

743

STRUCTURE OF THE PRECURSOR mRNA/GENE

743

PROCESSING OF CART PEPTIDES

743

DISTRIBUTION OF CART mRNA AND PEPTIDES

744

RECEPTORS AND SIGNALING CASCADES

745

BIOLOGICAL ACTIONS OF CART PEPTIDES WITHIN THE BRAIN AND PITUITARY

745

PHYSIOPATHOLOGICAL IMPLICATIONS

747

References

747

98: The Melanin-Concentrating Hormone

751

ABSTRACT

751

DISCOVERY

751

STRUCTURE OF THE PRECURSOR mRNA/GENE

752

DISTRIBUTION OF THE mRNA/PEPTIDES

754

PROCESSING OF THE MCH PRECURSOR

755

RECEPTORS AND SIGNALING CASCADES

755

ACTIVE STRUCTURE OF THE MCH PEPTIDE AND RECEPTOR CONFORMATION

757

BIOLOGICAL ACTIONS OF PRO-MCH-DERIVED PEPTIDES

757

PATHOPHYSIOLOGICAL IMPLICATIONS

758

References

759

99: CCK/Gastrin

761

ABSTRACT

761

DISCOVERY

761

STRUCTURE OF THE PRECURSOR mRNA/GENE

761

DISTRIBUTION OF CCK

761

PROCESSING OF THE PRECURSOR

762

RECEPTORS AND SIGNALING CASCADES

763

ACTIVE AND/OR SOLUTION CONFORMATION

764

BIOLOGICAL ACTIONS WITHIN THE BRAIN AND PITUITARY

764

PATHOPHYSIOLOGICAL IMPLICATIONS

765

References

765

100: The Hypocretins (Orexins)

767

ABSTRACT

767

DISCOVERY

767

STRUCTURE OF THE PRECURSOR mRNA/GENE

767

DISTRIBUTION OF THE mRNA

768

PROCESSING OF THE PRECURSOR

769

RECEPTORS AND SIGNALING CASCADES

769

INFORMATION ON ACTIVE AND/OR SOLUTION CONFORMATION

770

BIOLOGICAL ACTIONS WITHIN THE BRAIN

770

PATHOPHYSIOLOGICAL IMPLICATIONS

772

References

773

101: Ghrelin

777

ABSTRACT

777

DISCOVERY

777

STRUCURE OF THE PRECURSOR AND mRNA/GENE

777

DISTRIBUTION OF GHRELIN mRNA

778

PROCESSING OF THE GHRELIN PRECURSOR

778

RECEPTOR

780

BIOLOGICAL ACTIONS WITHIN THE BRAIN

780

PATHOPHYSIOLOGICAL IMPLICATIONS

780

References

781

102: Neurotensin

783

ABSTRACT

783

DISCOVERY OF NEUROTENSIN

783

STRUCTURE OF THE PRECURSOR mRNA/GENE

783

NT/N mRNA EXPRESSION IN BRAIN

784

PROCESSING OF THE PRECURSOR

784

RECEPTORS AND SIGNALING CASCADES

785

INFORMATION ON ACTIVE OR SOLUTION CONFORMATION

785

BRAIN FUNCTIONS

785

PATHOPHYSIOLOGICAL IMPLICATIONS

787

References

787

103: Neuromedin U (NMU): Brain Peptide

791

ABSTRACT

791

NMU DISCOVERY

791

STRUCTURE OF THE PRECURSOR mRNA/GENE

791

NMU DISTRIBUTION AND PROCESSING

791

NMU RECEPTORS

792

NMU1R

793

NMU2R

793

BIOLOGICAL ACTIONS OF NMU IN THE BRAIN

794

PATHOPHYSIOLOGICAL IMPLICATIONS

796

References

796

104: Galanin and GALP Systems in Brain—Molecular Pharmacology, Anatomy, and Putative Roles in Physiology and Pathology

799

ABSTRACT

799

DISCOVERY OF GALANIN AND GALANINLIKE PEPTIDE (GALP)

799

STRUCTURE AND REGULATION OF THE GALANIN AND GALP GENES

799

DISTRIBUTION OF GALANIN AND GALP mRNA AND PEPTIDE-IMMUNOREACTIVITY

800

NATURE AND PROCESSING OF GALANIN AND GALP PRECURSORS

800

GALANIN FAMILY RECEPTORS

801

CENTRAL ACTIONS OF GALANIN AND GALP IN NORMAL AND PATHOPHYSIOLOGY

802

References

806

105: Brain Tachykinins

809

ABSTRACT

809

DISCOVERY

809

STRUCTURE OF THE PRECURSOR mRNA/GENE

809

DISTRIBUTION OF THE mRNA

810

PROCESSING OF THE PRECURSOR

812

RECEPTORS AND SIGNALING CASCADES

813

ACTIVE AND SOLUTION CONFORMATION

813

BIOLOGICAL ACTIONS WITHIN THE BRAIN

814

PATHOPHYSIOLOGICAL IMPLICATIONS

815

References

815

106: CGRP and Adrenomedullin in the Brain

817

ABSTRACT

817

DISCOVERY

817

STRUCTURE OF THE PRECURSOR mRNA/GENE

817

DISTRIBUTION OF THE mRNA/PEPTIDE

819

CGRP

819

PROCESSING OF THE PRECURSOR

820

RECEPTORS AND SIGNALING CASCADES

821

PEPTIDE CONFORMATION

822

BIOLOGICAL ACTIONS WITHIN THE BRAIN

822

CGRP

822

PATHOLOGICAL IMPLICATIONS

823

Acknowledgments

823

References

823

107: The RFamide-Related Peptides

825

ABSTRACT

825

DISCOVERY OF THE MAMMALIAN RFAMIDERELATED PEPTIDES

825

STRUCTURE OF THE RFAMIDE-RELATED PEPTIDE PRECURSORS

825

PROCESSING OF THE RFAMIDE-RELATED PEPTIDE PRECURSORS

827

DISTRIBUTION OF RFAMIDE-RELATED PEPTIDES IN THE BRAIN

827

RFAMIDE-RELATED PEPTIDE RECEPTORS

829

INFORMATION ON SOLUTION CONFORMATION OF RFAMIDERELATED PEPTIDES

829

BIOLOGICAL ACTIONS OF RFAMIDERELATED PEPTIDES WITHIN THE BRAIN AND PITUITARY

829

References

830

108: Apelin: Discovery, Distribution, and Physiological Role

833

ABSTRACT

833

DISCOVERY

833

STRUCTURE OF THE PRECURSOR mRNA/GENE AND PROCESSING OF THE PRECURSOR

834

RECEPTORS AND SIGNALING CASCADES

834

DISTRIBUTION OF APELIN AND ITS RECEPTOR IN THE RAT BRAIN

835

BIOLOGICAL ACTIONS WITHIN THE BRAIN AND PITUITARY GLAND

835

PERIPHERAL CARDIOVASCULAR ACTIONS

838

CONCLUSION

838

Acknowledgments

838

References

838

109: Urotensin II and Urotensin II–Related Peptide

841

ABSTRACT

841

DISCOVERY

841

STRUCTURE

841

LOCALIZATION

842

RECEPTORS AND SIGNALING CASCADES

845

BIOLOGICAL ACTIONS WITHIN THE BRAIN

845

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL SIGNIFICANCE

846

References

846

110: Brain/B-Type Natriuretic Peptide (BNP) and C-Type Natriuretic Peptide (CNP)

851

ABSTRACT

851

DISCOVERY

851

STRUCTURE OF THE PRECURSOR mRNA AND GENE

853

DISTRIBUTION OF mRNA

853

PROCESSING OF PRECURSOR

855

RECEPTORS AND SIGNALING CASCADE

855

BIOLOGICAL ACTIONS IN THE BRAIN

856

PATHOPHYSIOLOGICAL IMPLICATIONS

856

References

857

111: Endozepines

859

ABSTRACT

859

DISCOVERY

859

STRUCTURE OF THE PRECURSOR mRNA/GENE

859

DISTRIBUTION OF DBI mRNA AND ENDOZEPINE IMMUNOREACTIVITY

859

PROCESSING OF DBI

861

RECEPTORS AND SIGNALING CASCADES

861

CONTROL OF BIOSYNTHESIS AND RELEASE OF ENDOZEPINES

862

INFORMATION ON SOLUTION CONFORMATION OF ENDOZEPINES

862

BIOLOGICAL ACTIONS OF ENDOZEPINES WITHIN THE BRAIN

863

PATHOPHYSIOLOGICAL IMPLICATIONS

863

References

864

112: KiSS-1/Metastin

867

ABSTRACT

867

DISCOVERY OF KiSS-1 SYSTEM

867

STRUCTURE OF THE KiSS-1 GENE

868

PROCESSING OF KiSS-1 PRECURSOR: THE KISSPEPTINS

868

DISTRIBUTION OF KiSS-1 mRNA/PROTEIN WITHIN THE BRAIN

868

GPR54 AS RECEPTOR FOR KISSPEPTINS: STRUCTURE AND SIGNALING CASCADES

870

BIOLOGICAL ACTIONS OF KiSSPEPTINS: BRAIN AND PITUITARY EFFECTS

870

PATHOPHYSIOLOGICAL IMPLICATIONS

872

Acknowledgments

873

References

873

XI: Endocrine Peptides Section

875

113: Role of Opioid Peptides in the Local Regulation of Endocrine Glands

875

ABSTRACT

875

INTRODUCTION

875

PITUITARY GLAND

875

PANCREATIC ISLETS

876

ADRENAL GLAND

876

CONCLUSION

877

References

877

114: Role of Tachykinin-Gene-Related Peptides in the Local Regulation of Endocrine Glands

879

ABSTRACT

879

INTRODUCTION

879

PITUITARY GLAND

879

THYROID GLAND

880

PARATHYROID GLAND

880

PANCREATIC ISLETS

880

ADRENAL GLAND

881

LEYDIG CELLS

881

OVARY

882

CONCLUSION

882

References

882

115: Neuropeptide Y and the Regulation of Endocrine Function

885

ABSTRACT

885

INTRODUCTION

885

NPY AND ADRENAL FUNCTION

885

NPY IN THE PANCREAS

886

NPY AND GONADAL FUNCTION

887

NPY AND THYROID FUNCTION

888

CONCLUSION

889

References

889

116: Effects of PACAP in the Local Regulation of Endocrine Glands

893

ABSTRACT

893

INTRODUCTION

893

EFFECTS ON THE PITUITARY GLAND

893

EFFECTS ON THE THYROID GLAND

895

EFFECTS OF PACAP ON THE ENDOCRINE TESTIS AND OVARY

895

EFFECTS OF PACAP ON THE ADRENAL

895

EFFECTS OF PACAP ON PANCREATIC ISLETS

896

References

897

117: Endothelins in the Local Regulation of Endocrine Glands

901

ABSTRACT

901

INTRODUCTION

901

PITUITARY GLAND

901

THYROID GLAND

902

PARATHYROID GLAND

902

PANCREATIC ISLETS

903

ADRENAL GLAND

903

LEYDIG CELLS

904

OVARY

904

CONCLUSION

905

References

905

118: Adrenomedullin and Related Peptides in the Local Regulation of Endocrine Glands

907

ABSTRACT

907

INTRODUCTION

907

PITUITARY

907

ADRENALS

908

ENDOCRINE PANCREAS

909

DIFFUSE ENDOCRINE SYSTEM OF THE GUT

910

OTHER ENDOCRINE ORGANS

910

CONCLUSION

911

Acknowledgments

911

References

911

119: Ghrelin in the Local Regulation of Endocrine Glands

915

ABSTRACT

915

INTRODUCTION

915

GHRELIN AND THE PITUITARY

915

GHRELIN AND THE THYROID

916

GHRELIN AND THE HEART AND CARDIOMYOCYTES

916

GHRELIN—A NOVEL PEPTIDE FOR CARTILAGE AND BONE HOMEOSTASIS

917

GHRELIN AND THE PANCREAS

917

GHRELIN AND THE ADRENAL CORTEX

918

GHRELIN AND THE REPRODUCTIVE SYSTEM

918

CONCLUSION

919

Acknowledgments

919

References

919

120: Atrial Natriuretic Peptide in Local Regulation of Endocrine Glands

923

ABSTRACT

923

DISCOVERY

923

STRUCTURE OF THE PRECURSOR mRNA GENE

923

DISTRIBUTION OF ANP mRNA

924

PROCESSING

924

RELEASE OF NPs

925

RECEPTORS AND SIGNALING CASCADE

925

BIOLOGICAL ACTIVITIES OF NPs

925

PATHOPHYSIOLOGICAL IMPLICATIONS

927

References

927

121: Galanin, Neurotensin, and Neuromedins in the Local Regulation of Endocrine Glands

929

ABSTRACT

929

INTRODUCTION

929

GALANIN

929

NEUROTENSIN

931

NEUROMEDINS

932

CONCLUSION

932

References

933

XII: Ingestive Peptides Section

935

122: Neuropeptide Y: A Conductor of the Appetite-Regulating Orchestra in the Hypothalamus

935

ABSTRACT

935

INTRODUCTION

935

NPY AND APPETITE

935

MECHANISM OF ACTION

936

REGULATION OF NPY SIGNALING AND APPETITE

937

PATHOPHYSIOLOGY

938

Acknowledgment

939

References

939

123: Hypothalamic Galanin and Ingestive Behavior: Relation to Dietary Fat, Alcohol, and Circulating Lipids

941

ABSTRACT

941

STIMULATORY EFFECTS OF GAL INJECTION ON INGESTIVE BEHAVIOR

941

EFFECTS PRODUCED BY MUTATIONS OF THE GAL GENE OR GAL RECEPTOR GENES

942

EFFECTS OF CIRCULATING HORMONES AND DIETARY CONDITIONS ON ENDOGENOUS GAL

942

SITES OF ACTION AND NEURAL NETWORKS AFFECTED

943

RECEPTORS AND SIGNALING PATHWAYS MEDIATING GAL EFFECTS ON INGESTIVE BEHAVIOR

944

GAL IN RELATION TO OTHER PEPTIDERGIC AND AMINERGIC SYSTEMS CONTROLLING INGESTIVE BEHAVIOR

944

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL CONSEQUENCES OF GAL’S ACTIONS

944

Acknowledgments

945

References

945

124: Effects of Melanocortins on Ingestive Behavior

949

ABSTRACT

949

EFFECTS OF THE MELANOCORTINS ON FEEDING BEHAVIOR

949

GENETIC STUDIES ON MELANOCORTIN ACTION

950

FUNCTIONAL RESPONSE OF THE MELANOCORTINS TO DIFFERING METABOLIC AND FEEDING STATES

951

NEUROANATOMY OF THE CENTRAL MELANOCORTIN SYSTEM

953

RECEPTORS AND SIGNALING PATHWAYS RESPONSIBLE FOR MELANOCORTIN ACTIONS ON INGESTIVE BEHAVIOR

954

INTERACTIONS OF THE MELANOCORTINS WITH OTHER PEPTIDERGIC/AMINERGIC SYSTEMS

955

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS

955

References

956

125: CART Peptide and Ingestive Behavior

959

ABSTRACT

959

DESCRIPTION OF CART PEPTIDE EFFECTS ON FEEDING BEHAVIOR

959

STUDIES FROM GENETIC MANIPULATIONS OR MUTATIONS

959

FUNCTIONAL RESPONSE OF CART TO DIFFERING METABOLIC AND FEEDING STATES

960

SITES OF ACTION AND NEURAL NETWORKS AFFECTED

960

RECEPTORS AND SIGNALING PATHWAYS RESPONSIBLE FOR INGESTIVE BEHAVIORS

961

INTERACTIONS WITH OTHER PEPTIDERGIC/AMINERGIC SYSTEMS

961

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS

962

References

962

126: Orexins and Opioids in Feeding Behavior

965

ABSTRACT

965

EFFECT OF OREXINS AND OPIOIDS ON FEEDING BEHAVIOR

965

STUDIES FROM GENETIC MANIPULATIONS OR MUTATIONS

967

FUNCTIONAL RESPONSE OF OREXINS AND OPIOIDS TO METABOLIC AND FEEDING STATES

967

OxA AND OPIOID LIGANDS AND RECEPTORS: SITES OF ACTION AND NEURAL NETWORKS AFFECTED

968

INTERACTIONS WITH OTHER PEPTIDERGIC/AMINERGIC SYSTEMS

969

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS

969

INTERACTION BETWEEN OxA AND OPIOIDS

970

CONCLUSION

970

References

970

127: Melanin-Concentrating Hormone

975

ABSTRACT

975

INTRODUCTION

975

EFFECTS OF MCH ON FEEDING BEHAVIOR

975

STUDIES FROM GENETIC MANIPULATIONS OR MUTATIONS

976

FUNCTIONAL RESPONSE OF THE PEPTIDE/GENE TO DIFFERING METABOLIC AND FEEDING STATES

976

SITES OF ACTION AND NEURAL NETWORKS AFFECTED

977

RECEPTORS AND SIGNALING PATHWAYS RESPONSIBLE FOR THE INGESTIVE EFFECTS

978

INTERACTIONS WITH OTHER PEPTIDERGIC/AMINERGIC SYSTEMS

978

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS

978

References

979

128: Corticotrophin-Releasing Hormone (CRH) and Ingestive Behavior

983

ABSTRACT

983

EFFECTS OF CRH AND UROCORTINS ON FEEDING BEHAVIOR

983

STUDIES FROM GENETIC MANIPULATIONS

984

METABOLIC REGULATION OF CRH AND CRH RECEPTORS

984

SITES OF ACTION AND NETWORKS MEDIATING CRH EFFECTS

984

RECEPTORS AND PATHWAYS MEDIATING THE EFFECTS OF CRH AND THE UROCORTINS ON FOOD INTAKE

985

INTERACTIONS WITH NEUROPEPTIDE SYSTEMS

985

PHYSIOLOGY AND PATHOPHYSIOLOGICAL IMPLICATIONS

986

References

986

129: Peptide YY (PYY) and Neuromedin U (NMU): Effects on Ingestive Behavior

991

ABSTRACT

991

INTRODUCTION

991

DISCOVERY

992

DISTRIBUTION AND RELEASE

992

RECEPTORS

992

THE ROLE OF NMU IN THE REGULATION OF ENERGY BALANCE

993

PYY

994

CONCLUSION

995

References

995

130: Ghrelin and Ingestive Behavior

999

ABSTRACT

999

GHRELIN ADMINISTRATION INDUCES FOOD INTAKE ACROSS SPECIES

999

THE GROWTH HORMONE SECRETAGOGUE RECEPTOR GHSR-1a MEDIATES GHRELIN-INDUCED FOOD INTAKE

1000

GHRELIN TARGETS THE HYPOTHALAMUS TO INCREASE FOOD INTAKE AND BODY WEIGHT

1000

OTHER HYPOTHALAMIC PATHWAYS INVOLVED IN GHRELIN-INDUCED HYPERPHAGIA

1001

EXTRA-HYPOTHALAMIC EFFECTS OF GHRELIN ON FOOD INTAKE

1002

PERIPHERAL GHRELIN LEVELS ARE REGULATED BY FOOD INTAKE

1002

References

1004

131: Cholecystokinin and Satiety

1007

ABSTRACT

1007

INTRODUCTION

1007

FEEDING ACTIONS OF PERIPHERAL CCK

1007

FEEDING ACTIONS OF CENTRAL CCK

1009

STUDIES WITH OLETF RATS AND CCK-A RECEPTOR KNOCKOUT MICE

1009

FUNCTIONAL RESPONSES TO PERIPHERAL CCK IN DIFFERING METABOLIC STATES

1010

SITES OF ACTION FOR PERIPHERAL CCK IN SATIETY

1011

RECEPTORS AND SIGNALING PATHWAYS MEDIATING CCK SATIETY

1011

INTERACTIONS WITH OTHER SIGNALING SYSTEMS

1012

PATHOPHYSIOLOGIAL IMPLICATIONS

1012

References

1012

132: Enterostatin, a Peptide Regulator of Dietary Fat Ingestion

1015

ABSTRACT

1015

INTRODUCTION

1015

ENTEROSTATIN EFFECTS ON FEEDING BEHAVIOR

1015

GENOMIC STUDIES

1016

FUNCTIONAL RESPONSES TO DIFFERING FEEDING AND METABOLIC CONDITIONS

1016

SITES OF ACTION AND NEURAL NETWORKS AFFECTED

1017

RECEPTORS AND SIGNALING PATHWAYS

1018

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS

1019

References

1019

133: Regulation of Feeding Behavior by Glucagonlike Peptide 1 (GLP-1)

1021

ABSTRACT

1021

EFFECTS OF GLP-1 ON FEEDING BEHAVIOR

1021

STUDIES FROM GENETIC MANIPULATIONS (KNOCKOUTS, TRANSGENICS) AND SYNTHETIC ANALOGS

1021

FUNCTIONAL RESPONSE OF THE GLP-1 PEPTIDE/GENE TO DIFFERING METABOLIC AND FEEDING STATES

1022

SITES OF ACTION AND NEURAL NETWORKS AFFECTED BY GLP-1

1022

GLP-1 RECEPTORS AND SIGNALING PATHWAYS RESPONSIBLE FOR THE INGESTIVE EFFECTS

1022

INTERACTIONS OF GLP-1 WITH OTHER PEPTIDERGIC/AMINERGIC SYSTEMS

1023

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS

1023

References

1024

134: Role of Amylin and Calcitonin-Gene-Related Peptide (CGRP) in the Control of Food Intake

1027

ABSTRACT

1027

INTRODUCTION

1027

CHARACTERIZATION OF THE EFFECTS OF AMYLIN AND CGRP ON FOOD INTAKE

1027

FOOD INTAKE IN KNOCKOUT ANIMALS

1028

FOOD INTAKE IN ANIMALS OVEREXPRESSING AMYLIN

1029

FOOD INTAKE IN ANIMALS DEFICIENT OF CGRP OR OVEREXPRESSING CGRP

1029

REGULATION OF AMYLIN AND CGRP SYNTHESIS AND SECRETION

1029

CENTRAL PATHWAYS MEDIATING THE ANORECTIC EFFECTS OF AMYLIN AND CGRP

1029

HYPOTHALAMIC INVOLVEMENT IN THE ANORECTIC ACTION OF PERIPHERAL AMYLIN

1030

RECEPTORS AND SIGNALING PATHWAYS

1030

INTERACTION WITH OTHER PEPTIDES REGULATING INGESTIVE BEHAVIOR

1031

INTERACTION BETWEEN AMYLIN AND METABOLITES

1031

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS

1031

CONCLUSION

1031

References

1031

135: Leptin and the Regulation of Feeding

1033

ABSTRACT

1033

LEPTIN AND FEEDING BEHAVIOR

1033

THE ABSENCE OF LEPTIN ACTION

1033

FUNCTIONAL RESPONSES TO LEPTIN DURING ALTERED METABOLIC STATES

1034

SITES OF LEPTIN ACTION

1034

LEPTIN RECEPTORS AND INTRACELLULAR SIGNALING PATHWAYS

1034

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS

1036

References

1037

136: Ingestive Peptides: Insulin

1039

ABSTRACT

1039

INTRODUCTION

1039

EFFECTS OF INSULIN ON FEEDING BEHAVIOR

1039

GENETIC AND MOLECULAR BIOLOGICAL MANIPULATIONS

1041

METABOLIC STATES

1041

SITE OF ACTION AND NEURAL NETWORKS AFFECTED

1042

RECEPTORS AND SIGNALING PATHWAYS

1042

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS

1042

CONCLUSION

1043

References

1043

XIII: Gastrointestinal Peptides Section

1045

137: Adrenomedullin in Gastrointestinal Function

1045

ABSTRACT

1045

INTRODUCTION

1045

STRUCTURE

1045

EXPRESSION AND DISTRIBUTION

1046

RELEASE

1046

RECEPTORS AND SIGNAL TRANSDUCTION PATHWAYS

1046

BIOLOGICAL ACTIONS

1047

CONCLUSION

1048

Acknowledgment

1048

References

1048

138: Calcitonin Gene-Related Peptide and Gastrointestinal Function

1051

ABSTRACT

1051

INTRODUCTION

1051

DISTRIBUTION OF CGRP IN THE GI TRACT

1051

CGRP RECEPTORS IN THE GI TRACT

1052

RELEASE OF CGRP IN THE GI TRACT

1053

PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS OF CGRP IN THE GI TRACT

1053

References

1056

139: Peripheral Cholecystokinin

1059

ABSTRACT

1059

DISCOVERY

1059

STRUCTURE OF THE PRECURSOR mRNA/GENE

1060

CHOLECYSTOKININ PEPTIDE DISTRIBUTION

1060

PROCESSING OF PREPROCHOLECYSTOKININ

1060

MOLECULAR FORMS OF CHOLECYSTOKININ

1062

CHOLECYSTOKININ RECEPTORS

1062

SOLUTION CONFORMATION

1063

PERIPHERAL BIOLOGICAL ACTIONS OF CHOLECYSTOKININ

1064

CONCLUSION

1066

References

1066

140: Corticotrophin-Releasing Hormone (CRH) Family in the Gastrointestinal System

1069

ABSTRACT

1069

INTRODUCTION

1069

EXPRESSION AND LOCATION OF CRH PEPTIDES AND RECEPTORS IN THE GI SYSTEM

1069

ACTIONS OF CRH AND RELATED PEPTIDES IN GI FUNCTIONS

1070

NEURONAL PATHWAYS INVOLVED IN CRH ACTIONS IN GI FUNCTIONS

1072

PATHOPHYSIOLOGICAL IMPLICATIONS

1072

Acknowledgment

1073

References

1073

141: Paneth Cell a-Defensins

1075

ABSTRACT

1075

DISCOVERY OF ENTERIC PANETH CELL a-DEFENSINS

1075

a-DEFENSIN GENE AND PRECURSOR STRUCTURES

1076

DISTRIBUTION OF a-DEFENSINS IN THE GASTROINTESTINAL TRACT

1078

STRUCTURES OF PANETH CELL a-DEFENSINS

1078

MECHANISMS OF ACTION

1078

PATHOPHYSIOLOGICAL IMPLICATIONS

1080

Acknowledgments

1080

References

1080

142: Galanin in the Gastrointestinal Tract: Distribution and Function

1083

ABSTRACT

1083

INTRODUCTION

1083

GALANIN DISTRIBUTION

1083

BIOLOGICAL EFFECTS OF GALANIN IN THE GASTROINTESTINAL TRACT

1084

GALANIN RECEPTORS

1084

INFLAMMATION AND INJURY

1087

Acknowledgment

1087

References

1087

143: Gastrin

1089

ABSTRACT

1089

DISCOVERY

1089

STRUCTURE OF THE GENE AND PRECURSOR

1089

DISTRIBUTION OF MRNA IN GUT

1090

RECEPTOR EXPRESSION AND REGULATION

1090

BIOLOGICAL ACTIONS ON GI TRACT

1090

PATHOPHYSIOLOGICAL IMPLICATIONS

1091

References

1091

144: Gastrin-Releasing Peptide

1093

ABSTRACT

1093

INTRODUCTION

1093

STRUCTURE OF THE PRECURSOR mRNA/GENE AND PEPTIDE VARIANTS

1093

DISTRIBUTION OF GRP-LIKE IMMUNOREACTIVITY, GRP mRNA, AND GRP RECEPTOR

1094

RECEPTOR SUBTYPES AND SIGNALING

1095

BIOLOGICAL ACTIONS WITHIN THE GI TRACT

1095

PATHOPHYSIOLOGICAL IMPLICATIONS

1099

References

1100

145: Glucagonlike Peptides 1 and 2, Enteroglucagon, Glicentin, and Oxyntomodulin

1103

ABSTRACT

1103

DISCOVERY AND STRUCTURE OF THE GENE

1103

EXPRESSION OF THE GENE

1104

ACTIVE CONFORMATION AND METABOLISM

1105

RECEPTOR EXPRESSION

1105

BIOLOGICAL ACTIONS

1106

ACTIONS OF GLP-1

1106

PATHOPHYSIOLOGICAL IMPLICATIONS

1109

References

1110

146: Ghrelin

1111

ABSTRACT

1111

ALTERNATIVE DISCOVERIES OF GHRELIN

1111

STRUCTURE OF THE PRECURSOR mRNA/GENE

1111

DISTRIBUTION IN THE GASTROINTESTINAL TRACT

1112

STRUCTURE–ACTIVITY RELATIONS OF GHRELIN AND OF THE GHRELIN RECEPTOR

1112

BIOLOGICAL ACTION ON THE GASTROINTESTINAL TRACT

1113

PATHOPHYSIOLOGICAL IMPLICATIONS AND THERAPEUTIC POTENTIAL

1114

Acknowledgments

1115

References

1115

147: Leptin and the Gastrointestinal Tract

1117

ABSTRACT

1117

INTRODUCTION

1117

THE STOMACH PRODUCES LEPTIN

1117

GASTRIC LEPTIN IS A NEUROENDOCRINE MOLECULE FOR SATIETY

1118

GASTRIC LEPTIN ENTERS THE INTESTINE

1118

LEPTIN REGULATES INTESTINAL ENDOCRINE SECRETIONS

1118

GUT LEPTIN AND INTESTINAL ABSORPTION OF NUTRIENTS

1119

LEPTIN AND GUT PATHOLOGIES

1120

CONCLUSION

1120

Acknowledgments

1121

References

1121

148: Motilin

1123

ABSTRACT

1123

DISCOVERY OF MOTILIN

1123

STRUCTURE OF MOTILIN AND RELATED PEPTIDES

1123

DISTRIBUTION IN THE GI TRACT

1125

STRUCTURE–ACTIVITY

1126

RECEPTOR

1126

BIOLOGICAL ACTIONS

1127

PATHOPHYSIOLOGICAL IMPLICATION

1129

Acknowledgments

1129

References

1130

149: Neurotensin in Regulation of Gastrointestinal Functions

1131

ABSTRACT

1131

INTRODUCTION

1131

NT INHIBITS MOTILITY AND SECRETION IN THE STOMACH AND SMALL INTESTINE

1132

NT ENHANCES COLONIC MOTILITY AND STIMULATES SECRETION

1132

ROLE OF NT AND NTR1 IN INTESTINAL INFLAMMATION

1133

NT PROMOTES CELL GROWTH, REGENERATION, AND HEALING OF THE GI MUCOSA

1133

NT AND COLONIC STRESS RESPONSES

1133

CONCLUSION

1134

References

1134

150: Pituitary Adenylate Cyclase Activating Polypeptide (PACAP)

1137

ABSTRACT

1137

PACAP IS A NEWLY DISCOVERED NEUROENTERIC PEPTIDE

1137

CLONING AND CHARACTERIZATION OF PAC1

1137

SIGNAL TRANSDUCTION OF PAC1

1138

LOCALIZATION OF PAC1

1138

PHYSIOLOGY OF PAC1 IN THE GASTROINTESTINAL TRACT

1139

CONCLUSION

1140

Acknowledgments

1140

References

1140

151: Pancreatic Polypeptide

1143

ABSTRACT

1143

DISCOVERY OF PANCREATIC POLYPEPTIDE AS IT RELATES TO THE GASTROINTESTINAL TRACT

1143

STRUCTURE OF THE PRECURSOR mRNA/GENE AND PEPTIDE VARIANTS

1144

DISTRIBUTION OF THE mRNA AND PROTEIN

1144

RECEPTOR SUBTYPES, SIGNALING, AND DISTRIBUTION

1145

BIOLOGICAL ACTIONS

1147

PHYSIOPATHOLOGICAL IMPLICATIONS

1149

References

1150

152: Peptide YY

1155

ABSTRACT

1155

INTRODUCTION

1155

STRUCTURE OF THE PYY GENE AND PYY BIOSYNTHESIS

1155

GASTROINTESTINAL DISTRIBUTION AND ONTOGENY OF INTESTINAL PYY

1155

REGULATION OF PYY SECRETION

1156

PYY RECEPTORS

1157

BIOLOGICAL ACTIONS ON THE GASTROINTESTINAL TRACT

1158

GROWTH PROMOTING ACTIONS OF PYY ON THE GASTROINTESTINAL TRACT

1159

INHIBITORY ACTION OF PYY(3–36) ON APPETITE AND FOOD INTAKE

1159

PATHOPHYSIOLOGY OF PYY

1159

References

1159

153: Secretin

1161

ABSTRACT

1161

DISCOVERY OF SECRETIN

1161

STRUCTURE OF SECRETIN, ITS PRECURSOR TRANSCRIPT, AND GENE

1161

DISTRIBUTION OF SECRETIN AND ITS mRNA

1162

SECRETIN RECEPTOR SUBTYPES, DISTRIBUTION, AND SIGNALING

1164

BIOLOGICAL ACTIONS OF SECRETIN IN THE GASTROINTESTINAL TRACT

1164

PATHOPHYSIOLOGY AND CLINICAL APPLICATION OF SECRETIN

1167

References

1167

154: Somatostatin

1169

ABSTRACT

1169

INTRODUCTION

1169

SOMATOSTATIN-14, SOMATOSTATIN-28 AND CORTISTATIN IN THE GASTROINTESTINAL TRACT

1169

SOMATOSTATIN RECEPTORS IN THE GASTROINTESTINAL TRACT

1170

BIOLOGICAL ACTION OF SOMATOSTATIN IN THE GASTROINTESTINAL TRACT

1170

SOMATOSTATIN AND SOMATOSTATIN RECEPTORS IN THE DISEASED GASTROINTESTINAL TRACT

1171

SOMATOSTATIN ANALOGS AND THEIR CLINICAL APPLICATIONS IN GASTROINTESTINAL DISEASE

1172

References

1173

155: Somatostatin Analogs in theGastrointestinal Tract

1177

ABSTRACT

1177

INTRODUCTION

1177

GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS

1177

SECRETORY DIARRHEAS

1179

ESOPHAGEAL VARICEAL HEMORRHAGE

1180

GI MOTILITY AND FUNCTIONAL GI DISORDERS

1180

POSTOPERATIVE COMPLICATIONS OF SURGERY

1181

BILIARY SYSTEM

1182

References

1182

156: Substance P and Related Tachykinins in the Gastrointestinal Tract

1185

ABSTRACT

1185

DISCOVERY OF TACHYKININS IN THE GUT

1185

DISTRIBUTION OF TACHYKININ mRNAS AND PEPTIDES IN THE GI TRACT

1185

TACHYKININ RECEPTOR SUBTYPES, SIGNALING, AND DISTRIBUTION IN THE GI TRACT

1186

BIOLOGICAL ACTIONS OF TACHYKININS IN THE GUT

1187

PATHOPHYSIOLOGICAL IMPLICATIONS OF TACHYKININS IN THE GI TRACT

1188

Acknowledgments

1190

References

1191

157: TFF (Trefoil Factor Family) Peptides

1193

ABSTRACT

1193

DISCOVERY

1193

STRUCTURE OF THE PRECURSOR mRNA/GENE

1193

EXPRESSION IN THE GI TRACT

1194

ACTIVE CONFORMATION, 3D STRUCTURE

1196

TFF RECEPTORS AND SIGNALING CASCADES

1196

BIOLOGICAL ACTIONS ON THE GI TRACT

1196

PATHOPHYSIOLOGICAL IMPLICATIONS

1198

Acknowledgments

1199

References

1199

158: Signaling by Vasoactive Intestinal Peptide in Gastrointestinal Smooth Muscle

1201

ABSTRACT

1201

INTRODUCTION

1201

INTERPLAY OF INHIBITORY NEUROTRANSMITTERS

1202

VIP RECEPTORS AND THEIR SIGNALING IN SMOOTH MUSCLE

1202

Acknowledgments

1205

References

1205

XIV: Cardiovascular Peptides Section

1209

159: Adrenomedullin and Its Related Peptides

1209

ABSTRACT

1209

DISCOVERY AND STRUCTURE OF AM

1209

STRUCTURE OF THE PRECURSOR mRNA/GENE

1209

DISTRIBUTION OF THE mRNA AND PEPTIDE IN THE CARDIOVASCULAR SYSTEM

1210

RECEPTORS AND THEIR DISTRIBUTION IN THE CARDIOVASCULAR SYSTEM

1211

BIOLOGICAL ACTIONS IN THE CARDIOVASCULAR SYSTEM

1211

PROADRENOMEDULLIN N-TERMINAL 20 PEPTIDE

1212

INFORMATION ON MOLECULAR FORM OF AM

1213

CLINICAL IMPLICATION OF AM IN CARDIOVASCULAR DISEASES

1213

CONCLUSION

1213

References

1214

160: Angiotensin II and Its Related Peptides

1215

ABSTRACT

1215

DISCOVERY

1215

STRUCTURE OF THE PEPTIDE AND COMPONENT OF RA SYSTEM

1215

DISTRIBUTION OF RA SYSTEM, PROCESSING, AND ENDOGENOUS FORM IN THE CARDIOVASCULAR SYSTEM

1216

RECEPTORS AND THEIR DISTRIBUTION IN THE CARDIOVASCULAR SYSTEM

1216

BIOLOGICAL ACTIONS AND PATHOPHYSIOLOGICAL IMPLICATION IN THE CARDIOVASCULAR SYSTEM

1217

References

1219

161: Bradykinin and Its Related Peptides

1221

ABSTRACT

1221

DISCOVERY

1221

STRUCTURE OF KININOGEN mRNA AND GENE

1221

DISTRIBUTION OF KININOGEN AND KALLIKREIN mRNA AND KININ PEPTIDES

1222

FORMATION OF KININ PEPTIDES

1222

METABOLISM OF KININ PEPTIDES

1223

KININ RECEPTORS AND THEIR DISTRIBUTION IN THE CARDIOVASCULAR SYSTEM

1224

ROLE OF KININ PEPTIDES IN HEALTH AND DISEASE STATES

1224

References

1224

162: Calcitonin Gene-Related Peptides

1227

ABSTRACT

1227

CALCITONIN GENE-RELATED PEPTIDE

1227

Acknowledgments

1230

References

1230

163: Endothelins

1233

ABSTRACT

1233

DISCOVERY

1233

STRUCTURE OF THE PRECURSOR mRNA/GENE AND PROCESSING

1233

PLASMA CONCENTRATION AND INACTIVATION OF ENDOTHELIN 1

1235

RECEPTORS AND THEIR DISTRIBUTION

1236

BIOLOGICAL ACTIONS IN THE CARDIOVASCULAR SYSTEM

1237

References

1238

164: Ghrelin: Its Therapeutic Potential in Heart Failure

1239

ABSTRACT

1239

INTRODUCTION

1239

DISCOVERY, STRUCTURE, AND SYNTHESIS

1240

RECEPTORS AND THEIR DISTRIBUTION

1240

BIOLOGICAL ACTINS

1240

CLINICAL APPLICATION OF GHRELIN

1241

CONCLUSION

1242

References

1242

165: Natriuretic Peptides in the Cardiovascular System

1245

ABSTRACT

1245

DISCOVERY OF NATRIURETIC PEPTIDES

1245

STRUCTURE OF THE PRECURSORS, mRNAs, AND GENES OF NPs

1246

DISTRIBUTION OF THE mRNA AND PEPTIDE IN THE CARDIOVASCULAR SYSTEM

1247

PROCESSING AND ENDOGENOUS FORMS OF NPs

1248

RECEPTORS OF NPs AND THEIR DISTRIBUTION IN THE CARDIOVASCULAR SYSTEM

1248

INFORMATION ON ACTIVE AND/OR SOLUTION CONFORMATION OF NPs

1249

BIOLOGICAL ACTIONS OF NPs IN THE CARDIOVASCULAR SYSTEM

1249

PATHOPHYSIOLOGICAL IMPLICATION OF NPs IN THE CARDIOVASCULAR SYSTEM

1250

References

1252

166: Urotensin and Its Related Peptides

1255

ABSTRACT

1255

INTRODUCTION

1255

UROCORTIN (UROTENSIN I)

1255

UROTENSIN II

1257

CONCLUSION

1258

References

1258

167: Vasoactive Intestinal Peptide

1261

ABSTRACT

1261

INTRODUCTION

1261

DISCOVERY

1262

DISTRIBUTION

1262

PROCESSING

1262

RECEPTORS

1263

BIOLOGICAL ACTIONS

1264

PATHOPHYSIOLOGY

1266

Acknowledgments

1267

References

1267

168: Cardiovascular Peptides: Vasopressin

1269

ABSTRACT

1269

DISCOVERY

1269

STRUCTURE OF THE PRECURSOR mRNA/GENE

1269

DISTRIBUTION OF THE mRNA

1269

PROCESSING

1269

RECEPTORS

1270

ACTIVE OR SOLUTION CONFORMATION

1270

BIOLOGICAL ACTIVITY

1270

PATHOPHYSIOLOGICAL IMPLICATIONS

1271

References

1272

XV: Renal Peptides Section

1273

169: Renal Effects of Neurohypophyseal Peptides

1273

ABSTRACT

1273

BRIEF HISTORY AND OVERVIEW OF THE NEUROHYPOPHYSEAL PEPTIDES

1273

BODY FLUID HOMEOSTASIS

1274

VASOPRESSIN AND OXYTOCIN RECEPTORS

1274

LOCALIZATION OF VASOPRESSIN AND OXYTOCIN RECEPTORS IN THE KIDNEY

1275

RENAL EFFECTS OF VASOPRESSIN

1275

RENAL EFFECTS OF OXYTOCIN

1277

References

1277

170: Renal Renin-Angiotensin System

1281

ABSTRACT

1281

INTRODUCTION

1281

DISTRIBUTION OF RENIN, ANGIOTENSINCONVERTING ENZYME, AND ANGIOTENSINOGEN IN THE KIDNEY

1281

INTRARENAL LEVELS OF ANGIOTENSIN II

1284

BIOLOGICAL ACTIONS OF INTRARENAL ANG II

1285

CONCLUSION

1286

References

1286

171: Renal Natriuretic Peptide System and Actions of Urodilatin

1289

ABSTRACT

1289

DISCOVERY AND FIRST DESCRIPTIONS OF URODILATIN

1289

METABOLISM OF URODILATIN IN THE KIDNEY AND ITS PHYSIOLOGICAL AND PHARMACOLOGICAL SIGNIFICANCE

1292

URODILATIN—CLINICAL IMPLICATIONS

1293

References

1294

172: ANP and Its Role in the Regulation of Renal Tubular Transport Processes

1297

ABSTRACT

1297

DISCOVERY OF ATRIAL NATRIURETIC PEPTIDE ACTIONS IN THE KIDNEY

1297

EFFECTS OF ANP ON TUBULAR TRANSPORT SYSTEMS

1297

References

1301

173: Adrenomedullin as a Renal Peptide

1303

ABSTRACT

1303

ADRENOMEDULLIN PEPTIDE

1303

AM RECEPTOR

1303

RENAL BIOLOGICAL ACTIONS OF AM

1304

RENOPROTECTIVE ACTIONS OF AM

1304

CLINICAL IMPLICATIONS OF AM IN ASSOCIATION WITH THE KIDNEY

1304

References

1305

174: Adrenomedullin 2/Intermedin

1309

ABSTRACT

1309

DISCOVERY

1309

STRUCTURE OF THE PRECURSOR mRNA AND GENE

1310

DISTRIBUTION OF mRNA

1312

PROCESSING OF THE PRECURSOR

1312

RECEPTORS AND SIGNALING CASCADE

1312

PATHOPHYSIOLOGICAL IMPLICATIONS

1313

References

1314

175: Renal Endothelin

1315

ABSTRACT

1315

BRIEF HISTORY OF ENDOTHELIN

1315

LOCALIZATION OF THE ET-1 SYSTEM IN THE KIDNEY

1315

RENAL HEMODYNAMIC EFFECTS OF ET-1

1316

ET-1 EFFECTS ON EXCRETORY FUNCTION

1316

RENAL ET-1 IN BLOOD PRESSURE REGULATION

1318

CONCLUSION

1319

References

1319

176: Prolactin and Kidney Function

1323

ABSTRACT

1323

INTRODUCTION

1323

CLASSICAL PRODUCTION SITE AND ACTIONS OF PROLACTIN

1323

PROLACTIN RECEPTORS

1324

PROLACTIN AND OSMOREGULATION

1324

PROLACTIN RECEPTORS IN THE MAMMALIAN KIDNEY

1324

RENAL PRODUCTION OF PROLACTIN

1325

RENAL ACTIONS OF PROLACTIN

1325

PROLACTIN AND RENAL FUNCTION IN HUMANS

1326

THE JURY IS STILL OUT ON THE RENAL ACTIONS OF PROLACTIN

1326

HAVE TRANSGENE METHODS CLARIFIED THE ISSUE?

1327

References

1327

XVI: Respiratory Peptides Section

1329

177: Therapeutic Potential of Adrenomedullin for Pulmonary Hypertension

1329

ABSTRACT

1329

INTRODUCTION

1329

DISCOVERY, STRUCTURE, AND SYNTHESIS

1329

RECEPTORS AND THEIR DISTRIBUTION

1329

BIOLOGICAL ACTIONS

1330

CLINICAL APPLICATION OF AM FOR PULMONARY HYPERTENSION

1331

CONCLUSION

1333

References

1333

178: Endothelin in the Airways

1335

ABSTRACT

1335

INTRODUCTION

1335

SYNTHESIS AND ELIMINATION OF ET-1

1336

ENDOTHELIN RECEPTOR SUBTYPES AND LOCALIZATION

1336

PATHOPHYSIOLOGICAL ROLE

1336

References

1337

179: PACAP’s Role in Pulmonary Function

1339

ABSTRACT

1339

GENE STRUCTURE AND DISTRIBUTION OF THE PRECURSOR mRNA

1339

RECEPTORS

1339

BIOLOGICAL ACTIONS WITHIN THE LUNG

1340

PATHOPHYSIOLOGICAL IMPLICATIONS

1342

THERAPEUTIC POTENTIAL

1343

References

1344

180: Tachykinins and Their Receptors in the Lung

1347

ABSTRACT

1347

TACHYKININ RECEPTOR PHARMACOLOGY

1347

TACHYKININ LOCALIZATION IN THE LUNG

1348

TACHYKININ RECEPTOR DISTRIBUTION IN THE LUNG

1348

TACHYKININ-MEDIATED BIOLOGICAL EFFECTS IN THE LUNG

1348

THERAPEUTIC POTENTIAL OF TACHYKININ NK1 RECEPTOR BLOCKADE

1349

THERAPEUTIC POTENTIAL OF TACHYKININ NK2 RECEPTOR BLOCKADE

1349

THERAPEUTIC POTENTIAL OF DUAL TACHYKININ NK1-NK2 RECEPTOR BLOCKADE

1349

THERAPEUTIC POTENTIAL OF BLOCKADE OF THE TACHYKININ NK3 RECEPTOR

1350

CONCLUSION

1350

References

1350

181: Vasoactive Intestinal Peptide

1353

ABSTRACT

1353

INTRODUCTION: VIP IN THE LUNG

1353

VIP AND ITS FAMILY OF PEPTIDES

1353

DISTRIBUTION AND LOCALIZATION

1353

BIOLOGICAL ACTIONS PERTINENT TO THE LUNG

1354

RECEPTORS

1355

SIGNAL TRANSDUCTION PATHWAYS

1355

PHYSIOLOGICAL ROLES

1355

VIP IN PULMONARY DISEASE

1355

THERAPEUTIC POTENTIAL

1356

References

1357

XVII: Opioid Peptides Section

1359

182: Proenkephalin-Derived Opioid Peptides

1359

ABSTRACT

1359

DISCOVERY OF THE ENKEPHALINS

1359

STRUCTURE OF THE PRECURSOR GENE

1359

DISTRIBUTION OF ENKEPHALIN mRNA AND PEPTIDE

1359

PROCESSING

1360

RECEPTORS

1360

BIOLOGICAL ACTIVITY OF ENKEPHALINS

1361

PATHOPHYSIOLOGICAL IMPLICATIONS

1362

References

1363

183: Prodynorphin-Derived Opioid Peptides

1365

ABSTRACT

1365

DISCOVERY

1365

STRUCTURE OF THE PRECURSOR mRNA/GENE

1365

PROCESSING

1366

RECEPTORS

1367

CONFORMATIONAL ANALYSIS OF DYN A(1–17)

1367

DYNORPHIN EXPRESSION IN THE CENTRAL NERVOUS SYSTEM AND POSSIBLE BIOLOGICAL ACTIONS

1367

PATHOPHYSIOLOGICAL IMPLICATIONS

1368

DRUG ABUSE AND DYNORPHINS

1369

DYNORPHIN EXPRESSION IN PERIPHERAL TISSUES

1369

PERSPECTIVE

1370

References

1370

184: POMC Opioid Peptides

1371

ABSTRACT

1371

INTRODUCTION

1371

DISCOVERY

1371

DISTRIBUTION

1371

PROCESSING

1372

RECEPTORS

1373

BIOLOGICAL ACTIONS

1374

PATHOPHYSIOLOGICAL IMPLICATIONS

1376

References

1376

185: Endomorphins as Endogenous Peptides for u-Opioid Receptor: Their Differences in the Pharmacological and Physiological Characters

1379

ABSTRACT

1379

DISCOVERY OF ENDOMORPHINS

1379

DISTRIBUTION OF THE ENDOMORPHIN-2- LIKE IMMUNOREACTIVE NEURONS IN THE CENTRAL NERVOUS SYSTEM

1380

DISTRIBUTION OF THE EM-1-LI NEURONS IN THE CENTRAL NERVOUS SYSTEM

1380

RECEPTOR SELECTIVITY AND ITS MODULATION

1381

BIOLOGICAL ACTIONS OF ENDOMORPHINS

1381

PATHOPHYSIOLOGICAL IMPLICATIONS OF ENDOMORPHINS

1382

CONCLUSION

1383

Acknowledgments

1383

References

1383

186: Casomorphins and Hemorphins—Opioid Active Peptides Released by Partial Hydrolysis of Structural Proteins

1385

ABSTRACT

1385

DISCOVERY OF THE b-CASOMORPHINS AND THE HEMORPHINS

1385

THE FORMATION OF b-CASOMORPHINS AND HEMORPHINS

1386

RECEPTOR SELECTIVITY AND ITS MODULATION

1387

BIOLOGICAL ACTIONS AND FUNCTIONAL RELEVANCE OF THE b-CASOMORPHINS AND HEMORPHINS

1387

IMPLICATIONS OF b-CASOMORPHINS AND HEMORPHINS IN PATHOPHYSIOLGY

1388

CONCLUSION

1389

Acknowledgments

1389

References

1389

187: Anti-Opioid Peptides

1391

ABSTRACT

1391

INTRODUCTION

1391

REGULATION OF OPIOID ANALGESIA BY CCK

1391

CCK GENE EXPRESSION IN RESPONSE TO OPIOID ANALGESIA

1392

CCK RELEASE IN RESPONSE TO OPIOID ANALGESIA

1393

CELLULAR AND MOLECULAR MECHANISMS FOR CCK-OPIOID INTERACTIONS

1393

REGULATION OF OPIOID ANALGESIA BY NPFF

1393

REGULATION OF OPIOID ANALGESIA BY NOCICEPTIN

1394

REGULATION OF u-OPIOID SYSTEMS BY MIF-1, TYR-MIF-1, AND TYR-W-MIF-1

1394

Acknowledgment

1395

References

1395

188: Nociceptin

1397

ABSTRACT

1397

DISCOVERY

1397

STRUCTURE OF PRECURSOR MRNA/GENE

1397

DISTRIBUTION OF MRNA AND PEPTIDE

1399

BIOSYNTHESIS AND DEGRADATION

1400

RECEPTOR

1400

BIOLOGICAL ACTIONS

1400

PATHOPHYSIOLOGICAL IMPLICATIONS

1402

References

1402

189: Role of Tachykinins in Spinal Nociceptive Mechanisms and Their Interactions with Opioids

1405

ABSTRACT

1405

DISTRIBUTION OF TACHYKININS IN DORSAL ROOT GANGLIA AND THE SPINAL CORD

1405

PLASTICITY OF THE EXPRESSION OF TACHYKININS AND THEIR RECEPTORS FOLLOWING INFLAMMATION AND NERVE INJURY

1405

RELEASE OF TACHYKININS IN THE SPINAL CORD

1406

INVOLVEMENT OF TACHYKININS IN SPINAL NOCICEPTION

1406

NK-1 RECEPTOR AND NEUROPATHIC PAIN

1406

SP-SAPORIN AND NK-1 RECEPTOR EXPRESSING LAMINAE I NEURONS IN NOCICEPTION

1407

INTERACTION BETWEEN TACHYKININS AND OPIOIDS

1407

THE FAILURE OF NK-1 ANTAGONISTS AS ANALGESICS IN HUMANS

1407

References

1408

190: Exorphin-Opioid Active Peptides of Exogenous Origin

1411

ABSTRACT

1411

OPIOID PEPTIDES DERIVED FROM PLANT PROTEINS

1411

OPIOID PEPTIDES DERIVED FROM ANIMAL PROTEINS

1412

INTRAPROTEIN OPIOID SEQUENCE

1414

CLASSIFICATION OF EXORPHINS ACCORDING TO THEIR STRUCTURE

1414

OPIOID ANTAGONIST AND ANTI-OPIOID PEPTIDE DERIVED FROM PROTEINS

1415

CONCLUSION

1416

Acknowledgments

1416

References

1416

191: Opioid-Substance P Chimeric Peptides

1419

ABSTRACT

1419

INTRODUCTION

1419

CROSS-INTERACTION OF TACHYKININ AND OPIOID SYSTEMS

1420

TACHYKININ ANTAGONIST–OPIOID AGONIST CHIMERIC COMPOUNDS

1420

TACHYKININ AGONIST–OPIOID AGONIST CHIMERIC COMPOUNDS

1421

CONCLUSION

1423

References

1423

XVIII: Neurotrophic Peptides Section

1425

192: VIP- and PACAP-Related Neuroprotection

1425

ABSTRACT

1425

DISCOVERY

1425

STRUCTURE OF THE PRECURSOR mRNA, DISTRIBUTION, AND PROCESSING

1425

VIP NEUROPROTECTION

1425

RECENT RESEARCH ON VIP: CONCENTRATING ON RECEPTORS AND MECHANISMS

1426

RECENT RESEARCH ON PACAP

1427

NAP: TREATMENT THROUGH A VIP-RELATED MECHANISM

1428

CONCLUSION

1428

Acknowledgments

1428

References

1428

193: Insulin-Like Growth Factor 1

1431

ABSTRACT

1431

DISCOVERY

1431

STRUCTURE OF PRECURSOR mRNA/GENE

1431

DISTRIBUTION OF THE mRNA

1432

PROCESSING

1433

RECEPTORS

1433

ACTIVE AND/OR SOLUTION CONFORMATION

1434

BIOLOGICAL ACTIONS

1434

PATHOPHYSIOLOGICAL IMPLICATIONS

1435

References

1436

194: Erythropoietin—A Hematopoietic Hormone with Emerging Diverse Activities

1439

ABSTRACT

1439

DISCOVERY

1439

STRUCTURE OF THE PRECURSOR Epo mRNA/GENE

1439

DISTRIBUTION OF Epo mRNA

1439

PROCESSING OF Epo

1440

THE Epo RECEPTOR

1440

Epo BIOLOGICAL ACTIONS

1440

PATHOPHYSIOLOGICAL IMPLICATIONS

1444

References

1445

195: Neuregulins

1447

ABSTRACT

1447

DISCOVERY AND STRUCTURE

1447

DISTRIBUTION AND PROCESSING

1447

RECEPTORS

1448

BIOLOGICAL ACTIONS

1449

Acknowledgments

1450

References

1451

196: The Neurotrophins

1453

ABSTRACT

1453

DISCOVERY OF NERVE GROWTH FACTOR

1453

STRUCTURE OF THE mRNA/GENE

1453

DISTRIBUTION OF THE mRNA

1453

PRECURSOR PROTEIN: PROCESSING AND ACTIVITY

1454

CONFORMATION

1454

RECEPTORS—BINDING SITES

1455

TRKA AND p75 RECEPTORS—STRUCTURE

1455

RECEPTOR SIGNALING

1456

NEUROTROPHINS—RETROGRADE TRANSPORT

1456

p75 RECEPTOR SIGNALING

1457

NEUROTROPHINS—PHYSIOLOGICAL ROLE AND ROLES IN PATHOLOGY

1457

CLINICAL PROSPECTS

1458

References

1458

XIX: Blood-Brain Barrier Peptides Section

1461

197: Amino Acid Transport Across the Blood–Brain Barrier

1461

ABSTRACT

1461

BRAIN AMINO ACID REGULATION

1461

BLOOD–BRAIN BARRIER AMINO ACID TRANSPORT

1462

TRANSPORT SYSTEMS

1462

CONCLUSION

1466

References

1467

198: Oligopeptide Transport at the Blood–Brain and Blood–CSF Barriers

1469

ABSTRACT

1469

INTRODUCTION

1469

BLOOD–BRAIN BARRIERS: GENERAL PROPERTIES

1469

OLIGOPEPTIDE TRANSPORT AT THE BBB

1470

PEPTIDASES AT THE BBB

1471

OLIGOPEPTIDE TRANSPORTERS AT THE CHOROID PLEXUS

1471

PEPTIDASES AT THE CHOROID PLEXUS

1472

PEPTIDE AND PEPTIDOMIMETIC DRUG TRANSPORT

1472

CONCLUSION

1473

Acknowledgments

1474

References

1474

199: Opiate Peptides and the Blood–Brain Barrier

1475

ABSTRACT

1475

INTRODUCTION

1475

STABILIZATION

1475

TARGETING

1476

CONCLUSION

1478

References

1478

200: Permeability of the Blood–Brain Barrier to Neurotrophic Peptides

1481

ABSTRACT

1481

INTRODUCTION

1481

METHODS TO STUDY PERMEATION OF PEPTIDES ACROSS THE BBB: IN VIVO AND IN VITRO MODELS

1481

BINDING PROTEINS THAT AFFECT THE STABILITY AND PERMEATION KINETICS: INTRAVENOUS DELIVERY VERSUS IN SITU BRAIN PERFUSION

1482

PRESENCE OF RECEPTORS AT THE APICAL OR BASOLATERAL SURFACE OF THE BBB: USEFUL OR NOT FOR PEPTIDE TRANSPORT?

1483

ADSORPTIVE ENDOCYTOSIS AND CHEMICAL MODIFICATIONS THAT ENHANCE DELIVERY ACROSS THE BBB

1483

THE INTRACELLULAR TRAFFICKING OF PEPTIDES THAT LEADS TO EXOCYTOSIS

1483

SPECIFIC EXAMPLES OF THE PHARMACOKINETICS OF BBB PERMEATION

1484

THE SITUATION OF THE PARTIALLY DISRUPTED BBB AND SELECTIVE REGULATION OF THE TRANSPORT SYSTEM IN PATHOPHYSIOLOGY

1484

ENHANCED DELIVERY OF NEUROTROPHIC PEPTIDES: HOW IT AFFECTS NEUROREGENERATION

1485

CONCLUSION

1485

Acknowledgment

1485

References

1485

201: Transport of Basic Peptides at the Blood–Brain Barrier

1489

ABSTRACT

1489

INTRODUCTION

1489

bFGF

1490

TRANSPORT MECHANISM

1492

PEPTIDE DELIVERY TO THE BRAIN VIA ADSORPTIVE-MEDIATED TRANSPORT

1492

CONCLUSION

1492

Acknowledgments

1492

References

1493

202: Fibroblast Growth Factor and the Blood–Brain Barrier

1495

ABSTRACT

1495

INTRODUCTION

1495

FGF-INDUCED PROTECTION OF CEREBRAL ENDOTHELIUM AND NEURONS

1496

FGF1 AND FGF2 TRANSPORT ACROSS THE BLOOD–BRAIN BARRIER

1496

FGF SECRETION BY MICROVASCULAR ENDOTHELIAL CELLS

1497

FGF MODULATION OF CEREBRAL ENDOTHELIAL CELLS

1497

FGF2 TRANSPORT AND REGULATORY PHENOMENA AT THE CHOROID PLEXUS

1497

THE CSF-EPENDYMAL-BRAIN INTERFACE

1498

MODELING OF PEPTIDE REGULATORY SYSTEMS: INTEGRATING MULTIPLE LIGANDS AND TRANSPORT INTERFACES

1498

CONCLUSION

1499

References

1499

203: Ingestive Peptides and the Blood–Brain Barrier

1501

ABSTRACT

1501

INTRODUCTION

1501

INSULIN

1501

LEPTIN

1502

GHRELIN

1503

OTHER INGESTIVE PEPTIDES AND PROTEINS: SPECIAL INTERACTIONS WITH THE BBB

1503

CONCLUSION

1504

References

1505

204: Functional Aspects of Vasoactive Peptides at the Blood–Brain Barrier

1507

ABSTRACT

1507

ANGIOTENSIN

1507

BRADYKININ

1508

INTERPLAY BETWEEN ANGIOTENSIN AND BRADYKININ

1509

SUBSTANCE P

1509

ATRIAL NATRIURETIC PEPTIDE

1510

ENDOTHELINS

1510

ADRENOMEDULLIN

1511

MISCELLANEOUS PEPTIDES WITH VASOACTIVE PROPERTIES IN THE CNS

1511

References

1512

205: Hypothalamic Neuropeptides and the Blood–Brain Barrier

1515

ABSTRACT

1515

INTRODUCTION

1515

THE CIRCUMVENTRICULAR ORGANS

1515

TRH

1516

GnRH

1516

CORTICOTROPIN-RELEASING HORMONE

1517

VASOPRESSIN (ANTIDIURETIC HORMONE)

1517

OXYTOCIN

1518

SOMATOSTATIN

1518

PACAP

1518

References

1518

206: Diseases Mediated by the BBB: From Alzheimer’s to Obesity

1521

ABSTRACT

1521

INTRODUCTION

1521

LEPTIN AND OBESITY

1521

AMYLOID b PROTEIN EFFLUX AND ALZHEIMER’S DISEASE

1522

METHIONINE ENKEPHALIN AND ALCOHOL WITHDRAWAL

1523

GLUT-1 DEFICIENCY SYNDROME

1523

INSULIN RESISTANCE IN SEPSIS

1524

CONCLUSION

1524

References

1524

XX: Other Peptide Topics

1527

207: Prebiotic Peptides

1527

ABSTRACT

1527

INTRODUCTION

1527

THE PRIMITIVE EARTH SCENARIO

1527

THE FORMATION OF AMINO ACIDS

1528

THE FORMATION OF PEPTIDES

1528

A PEPTIDE WORLD AS THE ORIGIN OF LIFE?

1530

References

1531

208: Mixture-Based Combinatorial Libraries

1533

ABSTRACT

1533

INTRODUCTION

1533

GENERAL METHODS

1533

m-RECEPTOR LIGANDS

1535

d-RECEPTOR LIGANDS

1536

k-RECEPTOR LIGANDS

1536

m-, d-, AND k-LIGANDS

1536

ORPHAN RECEPTOR LIGANDS

1536

TESTING MIXTURES IN VIVO

1537

CONCLUSION

1537

FUTURE STUDIES

1538

References

1538

209: Use of Synthetic Peptides for Structural and Functional Analyses of Viruses Like HIV

1541

ABSTRACT

1541

INTRODUCTION

1541

HIV-1-DERIVED SYNTHETIC PEPTIDES

1541

THE HIV-1-SPECIFIC VIRUS PROTEIN U

1542

STRUCTURE AND FUNCTION OF THE LENTIVIRAL PROTEIN R

1543

THE TRANS-ACTIVATOR OF TRANSCRIPTION (Tat) OF HIV-1

1544

THE HIV-1 PROTEASE

1545

THE HIV-1 p6 Gag PROTEIN

1546

THE HIV-1 Gag PROTEINS NC AND MA

1547

CONCLUSION

1547

Acknowledgments

1548

References

1548

210: Pheromone Peptides

1551

ABSTRACT

1551

INTRODUCTION

1551

BACTERIAL PHEROMONE PEPTIDES

1552

FUNGAL PHEROMONE PEPTIDES

1552

ARTHROPOD PHEROMONE PEPTIDES

1555

ANNELID PHEROMONE PEPTIDES

1556

MOLLUSK PHEROMONE PEPTIDES

1556

VERTEBRATE PHEROMONE PEPTIDES

1556

CONCLUSION

1557

References

1557

211: Fish Peptides

1561

ABSTRACT

1561

INTRODUCTION

1561

MELANIN-CONCENTRATING HORMONE

1561

UROTENSINS

1562

ADRENOMEDULLIN 2/INTERMEDIN

1562

STANNIOCALCINS

1563

CONCLUSION

1564

References

1564

212: Peptides and Sleep

1567

ABSTRACT

1567

INTRODUCTION

1567

HYPOTHALAMIC-PITUITARY-SOMATOTROPIC SYSTEM

1567

HYPOTHALAMIC-PITUITARYADRENOCORTICAL SYSTEM

1569

ACTH

1569

HYPOTHALAMIC-PITUITARY-THYROID SYSTEM

1570

OTHER PEPTIDES

1570

CONCLUSION

1571

Acknowledgment

1572

References

1572

213: Peptide Chronomics

1575

ABSTRACT

1575

PREAMBLE

1575

INTRODUCTION

1575

AVOIDING BLUNDERS

1578

CHRONOMICS SPAWNED BY CHRONOBIOLOGY MAPS DYNAMICS

1581

END POINTS

1581

SUSCEPTIBILITY RHYTHMS

1588

ATLAS

1588

BEGINNINGS OF OPPORTUNISTIC MAPPING ALONG THE SCALE OF YEARS

1588

MAPS OF PEPTIDES IN MEN

1593

PEPTIDE CHRONOMICS IN WOMEN

1593

BREAST CANCER RISK ASSESSMENT

1599

PROSTATE CANCER RISK ASSESSMENT

1599

DISCUSSION

1602

CONCLUSION

1603

Acknowledgments

1607

References

1607

Index

1611

Color Plates

1643